| 1256-7 | N Ab [Presence] in Serum or Plasma from Blood product unit | N Ab |
| 1257-5 | N Ab [Presence] in Serum or Plasma from donor | N Ab |
| 1258-3 | N Ab [Presence] in Serum or Plasma | N Ab |
| 1259-1 | N Ag [Presence] on Red Blood Cells from Blood product unit | N Ag |
| 1260-9 | N Ag [Presence] on Red Blood Cells from donor | N Ag |
| 1261-7 | N Ag [Presence] on Red Blood Cells | N Ag |
| 1262-5 | N NOS Ab [Presence] in Serum or Plasma from Blood product unit | N NOS Ab |
| 1263-3 | N NOS Ab [Presence] in Serum or Plasma from donor | N NOS Ab |
| 1264-1 | N NOS Ab [Presence] in Serum or Plasma | N NOS Ab |
| 1265-8 | N NOS Ag [Presence] on Red Blood Cells from Blood product unit | N NOS Ag |
| 1266-6 | N NOS Ag [Presence] on Red Blood Cells from donor | N NOS Ag |
| 1267-4 | N NOS Ag [Presence] on Red Blood Cells | N NOS Ag |
| 2643-5 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Serum | N-acetyl-beta-glucosaminidase |
| 33354-2 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Urine | N-acetyl-beta-glucosaminidase |
| 48995-5 | N-acetyl-beta-glucosaminidase/Creatinine [Ratio] in Urine | N-acetyl-beta-glucosaminidase/Creatinine |
| 33299-9 | N-acetyl-L-aspartate [Presence] in Urine | N-acetyl-L-aspartate |
| 34149-5 | N-acetyl-L-aspartate [Molecules/volume] in Amniotic Fluid | N-acetyl-L-aspartate |
| 13779-4 | N-acetyl-L-aspartate/Creatinine [Mass ratio] in Urine | N-acetyl-L-aspartate/Creatinine |
| 29631-9 | N-acetylaspartate [Presence] in Urine | N-acetylaspartate |
| 33212-2 | N-acetylaspartate [Mass/volume] in Body fluid | N-acetylaspartate |
| 34610-6 | N-acetylaspartate/Creatinine [Mass ratio] in Urine | N-acetylaspartate/Creatinine |
| 47710-9 | N-acetylaspartate/Creatinine [Molecular ratio] in Urine | N-acetylaspartate/Creatinine |
| 21413-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine | N-Acetylgalactosamine-4-Sulfatase |
| 24093-7 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast | N-Acetylgalactosamine-4-Sulfatase |
| 24094-5 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes | N-Acetylgalactosamine-4-Sulfatase |
| 2645-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Amniotic Fluid | N-Acetylgalactosamine-4-Sulfatase |
| 2646-8 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Serum | N-Acetylgalactosamine-4-Sulfatase |
| 2647-6 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Tissue | N-Acetylgalactosamine-4-Sulfatase |
| 2648-4 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Leukocytes | N-Acetylgalactosamine-4-Sulfatase |
| 24095-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast | N-Acetylgalactosamine-6-Sulfatase |
| 24096-0 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes | N-Acetylgalactosamine-6-Sulfatase |
| 2649-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue | N-Acetylgalactosamine-6-Sulfatase |
| 24097-8 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast | N-Acetylglucosamine-6-Sulfatase |
| 24098-6 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes | N-Acetylglucosamine-6-Sulfatase |
| 2650-0 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/volume] in Serum | N-Acetylglucosamine-6-Sulfatase |
| 34164-4 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue | N-Acetylglucosamine-6-Sulfatase |
| 14846-0 | N-acetylprocainamide [Molecules/volume] in Serum or Plasma | N-acetylprocainamide |
| 17317-9 | N-acetylprocainamide [Mass/volume] in Urine | N-acetylprocainamide |
| 17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid | N-acetylprocainamide |
| 3834-9 | N-acetylprocainamide [Mass/volume] in Serum or Plasma | N-acetylprocainamide |
| 4339-8 | N-acetylprocainamide [Mass] of Dose | N-acetylprocainamide |
| 29369-6 | N-acetylprocainamide/Procainamide [Mass ratio] in Serum or Plasma | N-acetylprocainamide/Procainamide |
| 29632-7 | N-acetyltyrosine [Presence] in Urine | N-acetyltyrosine |
| 13780-2 | N-acetyltyrosine/Creatinine [Mass ratio] in Urine | N-acetyltyrosine/Creatinine |
| 25119-9 | N-acetyltyrosine/Creatinine [Molecular ratio] in Urine | N-acetyltyrosine/Creatinine |
| 12603-7 | N-desalkylflurazepam [Presence] in Stool | N-desalkylflurazepam |
| 13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma | N-desalkylflurazepam |
| 14690-2 | N-desalkylflurazepam [Molecules/volume] in Serum or Plasma | N-desalkylflurazepam |
| 16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirm method | N-desalkylflurazepam |
| 19614-7 | N-desalkylflurazepam [Presence] in Urine by Screen method | N-desalkylflurazepam |
| 19615-4 | N-desalkylflurazepam [Presence] in Urine by Confirm method | N-desalkylflurazepam |
| 19617-0 | N-desalkylflurazepam [Mass/volume] in Urine | N-desalkylflurazepam |
| 26841-7 | N-desalkylflurazepam [Mass/mass] in Hair | N-desalkylflurazepam |
| 26866-4 | N-desalkylflurazepam [Mass/mass] in Meconium | N-desalkylflurazepam |
| 27194-0 | N-desalkylflurazepam [Mass/volume] in Vitreous fluid | N-desalkylflurazepam |
| 27436-5 | N-desalkylflurazepam [Mass/mass] in Stool | N-desalkylflurazepam |
| 35605-5 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method | N-desalkylflurazepam |
| 46980-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirm method | N-desalkylflurazepam |
| 47404-9 | N-desalkylflurazepam [Mass/volume] in Blood by Confirm method | N-desalkylflurazepam |
| 9652-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma | N-desalkylflurazepam |
| 19618-8 | N-desalkylflurazepam cutoff [Mass/volume] in Urine for Screen method | N-desalkylflurazepam cutoff |
| 19619-6 | N-desalkylflurazepam cutoff [Mass/volume] in Urine for Confirm method | N-desalkylflurazepam cutoff |
| 3620-2 | N-ethylnicotinamide [Mass/volume] in Urine | N-ethylnicotinamide |
| 3835-6 | None | N-ethylnicotinamide |
| 4248-1 | N-ethylnicotinamide [Mass] of Dose | N-ethylnicotinamide |
| 4340-6 | None | N-ethylnicotinamide |
| 35580-0 | N-methyl valine [Mass/volume] in Blood | N-methyl valine |
| 12542-7 | N-methylacetamide [Mass/volume] in Urine | N-methylacetamide |
| 27163-5 | N-methylacetamide/Creatinine [Mass ratio] in Urine | N-methylacetamide/Creatinine |
| 12714-2 | N-methylhistamine [Mass/volume] in Urine | N-methylhistamine |
| 26053-9 | N-methylhistamine [Molecules/time] in 24 hour Urine | N-methylhistamine |
| 34344-2 | N-methylhistamine [Molecules/volume] in 24 hour Urine | N-methylhistamine |
| 34345-9 | N-methylhistamine [Molecules/volume] in Urine | N-methylhistamine |
| 13781-0 | N-methylhistamine/Creatinine [Mass ratio] in Urine | N-methylhistamine/Creatinine |
| 34346-7 | N-methylhistamine/Creatinine [Molecular ratio] in Urine | N-methylhistamine/Creatinine |
| 44340-8 | N-methylhistamine/Creatinine [Mass ratio] in 24 hour Urine | N-methylhistamine/Creatinine |
| 14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine | N-methylimidazoleacetate |
| 38712-6 | N-nitrosodimethylamine [Mass/volume] in Air | N-nitrosodimethylamine |
| 38713-4 | N-nitrosomorpholine [Mass/volume] in Air | N-nitrosomorpholine |
| 38367-9 | N-octanoylglycine/Creatinine [Mass ratio] in Urine | N-octanoylglycine/Creatinine |
| 42028-1 | None | NAACCR ambiguous terminology as basis for diagnosis |
| 42023-2 | None | NAACCR facility identification system coding system |
| 42024-0 | None | NAACCR hispanic identification algorithm hispanic origin |
| 42022-4 | None | NAACCR hospital tumor registration.permanent |
| 42025-7 | None | NAACCR Indian Health Service linkage |
| 35350-8 | None | NAACCR survival to last contact (in months) |
| 12405-7 | Nabumetone [Mass/volume] in Serum or Plasma | Nabumetone |
| 35497-7 | NADH cytochrome C reductase [Enzymatic activity/mass] in Tissue | NADH cytochrome C reductase |
| 2651-8 | NADH dehydrogenase [Enzymatic activity/volume] in Plasma | NADH dehydrogenase |
| 2652-6 | NADH dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | NADH dehydrogenase |
| 35496-9 | NADH dehydrogenase [Enzymatic activity/mass] in Tissue | NADH dehydrogenase |
| 2653-4 | NADH methemoglobin reductase [Mass/volume] in Red Blood Cells | NADH methemoglobin reductase |
| 32703-1 | NADH methemoglobin reductase [Enzymatic activity/mass] in Red Blood Cells | NADH methemoglobin reductase |
| 51603-9 | NADH methemoglobin reductase [Presence] in Red Blood Cells | NADH methemoglobin reductase |
| 12406-5 | Nadolol [Mass/volume] in Serum or Plasma | Nadolol |
| 3836-4 | Nadolol [Presence] in Urine | Nadolol |
| 3837-2 | Nadolol [Mass/volume] in Urine | Nadolol |
| 3838-0 | Nadolol [Mass/time] in 24 hour Urine | Nadolol |
| 4341-4 | Nadolol [Mass] of Dose | Nadolol |
| 6624-1 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Naegleria fowleri Ab |
| 6625-8 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay | Naegleria fowleri Ab |
| 7971-5 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid | Naegleria fowleri Ab |
| 41444-1 | Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by Probe & target amplification method | Naegleria fowleri DNA |
| 10694-8 | Naegleria sp identified in Tissue by Organism specific culture | Naegleria sp identified |
| 10695-5 | Naegleria sp identified in Tissue by Wet preparation | Naegleria sp identified |
| 10993-4 | Nafcillin [Mass/volume] in Serum or Plasma | Nafcillin |
| 18951-4 | Nafcillin [Susceptibility] | Nafcillin |
| 25232-0 | Nafcillin [Mass/volume] in Unspecified specimen | Nafcillin |
| 346-7 | Nafcillin [Susceptibility] by Minimum lethal concentration (MLC) | Nafcillin |
| 347-5 | Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nafcillin |
| 348-3 | Nafcillin [Susceptibility] by Disk diffusion (KB) | Nafcillin |
| 349-1 | Nafcillin [Susceptibility] by Serum bactericidal titer | Nafcillin |
| 41704-8 | Nafcillin [Susceptibility] by Gradient strip (E-test) | Nafcillin |
| 53877-7 | NAGS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NAGS gene mutation analysis |
| 39113-6 | None | Nail angle |
| 45804-2 | None | Nails &or calluses trimmed during last 90 days |
| 23312-2 | None | Nairobi sheep disease virus Ab |
| 23313-0 | Nairobi sheep disease virus Ab [Titer] in Serum | Nairobi sheep disease virus Ab |
| 23314-8 | Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID) | Nairobi sheep disease virus Ab |
| 23315-5 | Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence | Nairobi sheep disease virus Ab |
| 23316-3 | Nairobi sheep disease virus Ab [Presence] in Serum | Nairobi sheep disease virus Ab |
| 23317-1 | None | Nairobi sheep disease virus Ab |
| 31524-2 | Nairobi sheep disease virus Ab [Units/volume] in Serum | Nairobi sheep disease virus Ab |
| 23318-9 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Complement fixation | Nairobi sheep disease virus Ag |
| 23319-7 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence | Nairobi sheep disease virus Ag |
| 23320-5 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunoassay | Nairobi sheep disease virus Ag |
| 31904-6 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen | Nairobi sheep disease virus Ag |
| 16218-0 | Nalbuphine [Presence] in Urine by Confirm method | Nalbuphine |
| 17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma | Nalbuphine |
| 19605-5 | Nalbuphine [Presence] in Urine by Screen method | Nalbuphine |
| 20551-8 | Nalbuphine [Mass/volume] in Urine by Confirm method | Nalbuphine |
| 3839-8 | Nalbuphine [Presence] in Urine | Nalbuphine |
| 3840-6 | Nalbuphine [Mass/volume] in Urine | Nalbuphine |
| 3841-4 | Nalbuphine [Mass/time] in 24 hour Urine | Nalbuphine |
| 4342-2 | Nalbuphine [Mass] of Dose | Nalbuphine |
| 9777-4 | Nalbuphine [Mass/volume] in Unspecified specimen | Nalbuphine |
| 19607-1 | Nalbuphine cutoff [Mass/volume] in Urine for Screen method | Nalbuphine cutoff |
| 19608-9 | Nalbuphine cutoff [Mass/volume] in Urine for Confirm method | Nalbuphine cutoff |
| 17319-5 | Nalidixate [Mass/volume] in Serum or Plasma | Nalidixate |
| 18952-2 | Nalidixate [Susceptibility] | Nalidixate |
| 25261-9 | Nalidixate [Mass/volume] in Unspecified specimen | Nalidixate |
| 350-9 | Nalidixate [Susceptibility] by Minimum lethal concentration (MLC) | Nalidixate |
| 351-7 | Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC) | Nalidixate |
| 352-5 | Nalidixate [Susceptibility] by Disk diffusion (KB) | Nalidixate |
| 353-3 | Nalidixate [Susceptibility] by Serum bactericidal titer | Nalidixate |
| 7034-2 | Nalidixate [Susceptibility] by Gradient strip (E-test) | Nalidixate |
| 3842-2 | Nalorphine [Mass/volume] in Urine | Nalorphine |
| 4343-0 | Nalorphine [Mass] of Dose | Nalorphine |
| 28061-0 | Naloxone [Mass/volume] in Serum or Plasma | Naloxone |
| 42618-9 | Naloxone [Presence] in Urine by Screen method | Naloxone |
| 10994-2 | Naltrexone [Mass/volume] in Serum or Plasma | Naltrexone |
| 12309-1 | Naltrexone [Presence] in Urine | Naltrexone |
| 18334-3 | Naltrexone [Presence] in Urine by Confirm method | Naltrexone |
| 19609-7 | Naltrexone [Presence] in Urine by Screen method | Naltrexone |
| 19610-5 | Naltrexone [Mass/volume] in Urine by Confirm method | Naltrexone |
| 19611-3 | Naltrexone [Mass/volume] in Urine | Naltrexone |
| 19612-1 | Naltrexone cutoff [Mass/volume] in Urine for Screen method | Naltrexone cutoff |
| 19613-9 | Naltrexone cutoff [Mass/volume] in Urine for Confirm method | Naltrexone cutoff |
| 19132-0 | None | Name |
| 41972-1 | None | Name |
| 45965-1 | None | Name |
| 52418-1 | None | Name |
| 52421-5 | None | Name |
| 52425-6 | None | Name |
| 52458-7 | None | Name |
| 54125-0 | None | Name |
| 54138-3 | None | Name |
| 18606-4 | Current medication name and identifier (DEEDS 5.09) | Name + ID |
| 18611-4 | Medication administered, name + identifier | Name + ID |
| 18618-9 | Medication discharge, name + identifier | Name + ID |
| 42127-1 | None | Name of follow-up contact |
| 45395-1 | None | Name suffix |
| 3843-0 | Nandrolone [Presence] in Urine | Nandrolone |
| 3844-8 | Nandrolone [Mass/volume] in Urine | Nandrolone |
| 3845-5 | Nandrolone [Mass/time] in 24 hour Urine | Nandrolone |
| 4344-8 | Nandrolone [Mass] of Dose | Nandrolone |
| 12435-4 | Naphthalene [Mass/volume] in Serum or Plasma | Naphthalene |
| 38612-8 | Naphthalene [Mass/volume] in Air | Naphthalene |
| 12436-2 | Naphthol [Mass/volume] in Serum or Plasma | Naphthol |
| 33300-5 | Naproxen [Presence] in Urine by Screen method | Naproxen |
| 3846-3 | Naproxen [Mass/volume] in Serum or Plasma | Naproxen |
| 4345-5 | Naproxen [Mass] of Dose | Naproxen |
| 50885-3 | Naproxen [Molecules/volume] in Serum or Plasma | Naproxen |
| 45429-8 | None | Naps regularly during day |
| 50027-2 | Narcissus IgE Ab [Units/volume] in Serum | Narcissus sp Ab.IgE |
| 38553-4 | Narcolepsy associated Ag [Presence] in Serum or Plasma | Narcolepsy associated Ag |
| 12554-2 | Narcotics and opioids [Identifier] in Urine | Narcotics |
| 29376-1 | Narcotics and opioids [Identifier] in Blood | Narcotics |
| 29377-9 | Narcotics and opioids [Identifier] in Gastric fluid | Narcotics |
| 31088-8 | Narcotics and opioids [Identifier] in Bile fluid | Narcotics |
| 50398-7 | Narrative diagnostic report [interpretation] in Blood or Tissue by Molecular genetics method Narrative | Narrative diagnostic report |
| 19979-4 | None | Nasal cannula types |
| 9036-5 | None | Nasogastric tube site |
| 49598-6 | Natalizumab Ab [Presence] in Serum by Immunoassay | Natalizumab Ab |
| 32597-7 | Natamycin [Susceptibility] | Natamycin |
| 49487-2 | Nateglinide [Presence] in Serum or Plasma | Nateglinide |
| 49702-4 | Nateglinide [Mass/volume] in Serum or Plasma | Nateglinide |
| 52869-5 | None | Nation catchment area |
| 45952-9 | None | National provider ID |
| 44763-1 | None | Native inferior vena cava liver graft attachment |
| 30934-4 | Natriutietic peptide B [Mass/volume] in Serum or Plasma | Natriuretic peptide.B |
| 35257-5 | Natriutietic peptide B [Mass or Molecules/volume] in Serum or Plasma | Natriuretic peptide.B |
| 42637-9 | Natriutietic peptide B [Mass/volume] in Blood | Natriuretic peptide.B |
| 47092-2 | Natriutietic peptide B [Molecules/volume] in Serum or Plasma | Natriuretic peptide.B |
| 33762-6 | Natriuretic peptide.B prohormone [Mass/volume] in Serum or Plasma | Natriuretic peptide.B prohormone |
| 33763-4 | Natriuretic peptide.B prohormone [Molecules/volume] in Serum or Plasma | Natriuretic peptide.B prohormone |
| 34439-0 | Natural killer cell function [Units/volume] in Blood | Natural killer cell function |
| 53759-7 | Natural killer cell panel in Blood by Flow cytometry (FC) | Natural killer cell panel |
| 28391-1 | None | Nausea |
| 42848-2 | None | Nausea |
| 52872-9 | None | Nautical catchment area |
| 21716-6 | NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NB gene mutation analysis |
| 22067-3 | NB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | NB gene mutations tested for |
| 48732-2 | NCF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NCF1 gene mutation analysis |
| 48728-0 | NCF1+NCF2+CYBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NCF1+NCF2+CYBB gene mutation analysis |
| 47966-7 | NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NCF2 gene mutation analysis |
| 48733-0 | NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NCF2 gene mutation analysis |
| 51726-8 | None | NDC labeler code request |
| 46669-8 | None | Near acuity |
| 44704-5 | NEB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NEB gene mutation analysis |
| 48793-4 | Necroinflammatory activity grade | Necroinflammatory activity grade |
| 48792-6 | Necroinflammatory activity score | Necroinflammatory activity score |
| 28161-8 | None | Need help letting go |
| 12544-3 | Nefazodone [Mass/volume] in Serum or Plasma | Nefazodone |
| 17320-3 | Nefazodone [Mass/volume] in Urine | Nefazodone |
| 25484-7 | Nefazodone [Molecules/volume] in Serum or Plasma | Nefazodone |
| 34740-1 | NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NEFL gene mutation analysis |
| 41079-5 | NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NEFL gene mutation analysis |
| 28305-1 | None | Neglect.behavior |
| 28426-5 | None | Neglect.behavior |
| 46837-1 | None | Neglect.behavior |
| 28306-9 | None | Neglect.knowledge |
| 28443-0 | None | Neglect.knowledge |
| 46838-9 | None | Neglect.knowledge |
| 28307-7 | None | Neglect.status |
| 28444-8 | None | Neglect.status |
| 46839-7 | None | Neglect.status |
| 28223-6 | None | Neighborhood &or workplace safety.behavior |
| 28308-5 | None | Neighborhood &or workplace safety.behavior |
| 46840-5 | None | Neighborhood &or workplace safety.behavior |
| 28224-4 | None | Neighborhood &or workplace safety.knowledge |
| 28309-3 | None | Neighborhood &or workplace safety.knowledge |
| 46841-3 | None | Neighborhood &or workplace safety.knowledge |
| 28225-1 | None | Neighborhood &or workplace safety.status |
| 28310-1 | None | Neighborhood &or workplace safety.status |
| 46842-1 | None | Neighborhood &or workplace safety.status |
| 52862-0 | None | Neighborhood catchment area |
| 14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture | Neisseria gonorrhoeae |
| 30099-6 | Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture | Neisseria gonorrhoeae |
| 688-2 | Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture | Neisseria gonorrhoeae |
| 689-0 | None | Neisseria gonorrhoeae |
| 690-8 | Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture | Neisseria gonorrhoeae |
| 691-6 | Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture | Neisseria gonorrhoeae |
| 692-4 | Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture | Neisseria gonorrhoeae |
| 693-2 | Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture | Neisseria gonorrhoeae |
| 694-0 | Neisseria gonorrhoeae [Presence] in Semen by Organism specific culture | Neisseria gonorrhoeae |
| 695-7 | Neisseria gonorrhoeae [Presence] in Synovial fluid by Organism specific culture | Neisseria gonorrhoeae |
| 696-5 | Neisseria gonorrhoeae [Presence] in Throat by Organism specific culture | Neisseria gonorrhoeae |
| 697-3 | Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture | Neisseria gonorrhoeae |
| 698-1 | Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture | Neisseria gonorrhoeae |
| 22430-3 | Neisseria gonorrhoeae Ab [Titer] in Serum | Neisseria gonorrhoeae Ab |
| 27021-5 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid by Complement fixation | Neisseria gonorrhoeae Ab |
| 31525-9 | Neisseria gonorrhoeae Ab [Units/volume] in Cerebral spinal fluid | Neisseria gonorrhoeae Ab |
| 32704-9 | Neisseria gonorrhoeae Ab [Presence] in Serum | Neisseria gonorrhoeae Ab |
| 42987-8 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid | Neisseria gonorrhoeae Ab |
| 5261-3 | Neisseria gonorrhoeae Ab [Units/volume] in Serum | Neisseria gonorrhoeae Ab |
| 9568-7 | Neisseria gonorrhoeae Ab [Titer] in Serum by Complement fixation | Neisseria gonorrhoeae Ab |
| 53762-1 | Neisseria gonorrhoeae IgG Ab [Titer] in Serum | Neisseria gonorrhoeae Ab.IgG |
| 29311-8 | Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria gonorrhoeae Ag |
| 31905-3 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen | Neisseria gonorrhoeae Ag |
| 31906-1 | Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen | Neisseria gonorrhoeae Ag |
| 6487-3 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay | Neisseria gonorrhoeae Ag |
| 6488-1 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunofluorescence | Neisseria gonorrhoeae Ag |
| 6489-9 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Latex agglutination | Neisseria gonorrhoeae Ag |
| 6490-7 | Neisseria gonorrhoeae Ag [Presence] in Urethra | Neisseria gonorrhoeae Ag |
| 21414-8 | Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 21415-5 | Neisseria gonorrhoeae DNA [Presence] in Urethra by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 21416-3 | Neisseria gonorrhoeae DNA [Presence] in Urine by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 24111-7 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 32705-6 | Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 35735-0 | Neisseria gonorrhoeae DNA [Presence] in Conjunctival specimen by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 43403-5 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe & signal amplification method | Neisseria gonorrhoeae DNA |
| 47387-6 | Neisseria gonorrhoeae DNA [Presence] in Genital specimen by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 50326-8 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen from donor by Probe & target amplification method | Neisseria gonorrhoeae DNA |
| 23908-7 | None | Neisseria gonorrhoeae rRNA |
| 32198-4 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by DNA probe | Neisseria gonorrhoeae rRNA |
| 32199-2 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by DNA probe | Neisseria gonorrhoeae rRNA |
| 33904-4 | Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by DNA probe | Neisseria gonorrhoeae rRNA |
| 39557-4 | None | Neisseria gonorrhoeae rRNA |
| 43305-2 | Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
| 5028-6 | Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe | Neisseria gonorrhoeae rRNA |
| 50388-8 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
| 50412-6 | Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen from donor by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
| 53878-5 | Neisseria gonorrhoeae rRNA [Presence] in Penis by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
| 53879-3 | Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
| 53927-0 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe & target amplification method | Neisseria gonorrhoeae rRNA |
| 6491-5 | None | Neisseria gonorrhoeae rRNA |
| 24019-2 | None | Neisseria meningitdis B Ag |
| 16134-9 | Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture | Neisseria meningitidis |
| 44093-3 | Neisseria meningitidis [Identifier] in Isolate by Organism specific culture | Neisseria meningitidis |
| 45183-1 | Neisseria meningitidis [Identifier] in Isolate by Agglutination | Neisseria meningitidis |
| 13271-2 | Neisseria meningitidis A Ab [Units/volume] in Serum | Neisseria meningitidis A Ab |
| 28546-0 | Neisseria meningitidis A IgG Ab [Mass/volume] in Serum by Immunoassay | Neisseria meningitidis A Ab.IgG |
| 31526-7 | Neisseria meningitidis A IgG Ab [Units/volume] in Serum | Neisseria meningitidis A Ab.IgG |
| 42986-0 | Neisseria meningitidis A IgG Ab [Mass/volume] in Serum | Neisseria meningitidis A Ab.IgG |
| 17326-0 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis A Ag |
| 30094-7 | Neisseria meningitidis A Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis A Ag |
| 31907-9 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis A Ag |
| 31908-7 | Neisseria meningitidis A Ag [Presence] in Unspecified specimen | Neisseria meningitidis A Ag |
| 42369-9 | Neisseria meningitidis A Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis A Ag |
| 6493-1 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis A Ag |
| 6494-9 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis A Ag |
| 6495-6 | Neisseria meningitidis A Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis A Ag |
| 41844-2 | Neisseria meningitidis A+B+C+W135+Y+Escherichia coli K1 Ag [Presence] in Serum by Agglutination | Neisseria meningitidis A+B+C+w135+Y+Escherichia coli K1 Ag |
| 41845-9 | Neisseria meningitidis A+B+C+W135+Y+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Agglutination | Neisseria meningitidis A+B+C+w135+Y+Escherichia coli K1 Ag |
| 41846-7 | Neisseria meningitidis A+B+C+W135+Y+Escherichia coli K1 Ag [Presence] in Urine by Agglutination | Neisseria meningitidis A+B+C+w135+Y+Escherichia coli K1 Ag |
| 19133-8 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
| 19259-1 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
| 31909-5 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis A+C+w135+Y Ag |
| 31910-3 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Unspecified specimen | Neisseria meningitidis A+C+w135+Y Ag |
| 32706-4 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Urine | Neisseria meningitidis A+C+w135+Y Ag |
| 33396-3 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Serum | Neisseria meningitidis A+C+w135+Y Ag |
| 33397-1 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Serum by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
| 33398-9 | Neisseria meningitidis A+C+W135+Y Ag [Presence] in Urine by Latex agglutination | Neisseria meningitidis A+C+w135+Y Ag |
| 42341-8 | Neisseria meningitidis A+W135 Ag [Presence] in Body fluid | Neisseria meningitidis A+w135 Ag |
| 17321-1 | Neisseria meningitidis A+Y Ag [Presence] in Urine | Neisseria meningitidis A+Y Ag |
| 20487-5 | Neisseria meningitidis A+Y Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis A+Y Ag |
| 32848-4 | Neisseria meningitidis A+Y Ag [Presence] in Unspecified specimen | Neisseria meningitidis A+Y Ag |
| 32851-8 | Neisseria meningitidis A+Y Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis A+Y Ag |
| 17322-9 | Neisseria meningitidis Ab [Presence] in Serum | Neisseria meningitidis Ab |
| 17323-7 | Neisseria meningitidis Ag [Presence] in Urine | Neisseria meningitidis Ag |
| 17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis Ag |
| 31911-1 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid | Neisseria meningitidis Ag |
| 31912-9 | Neisseria meningitidis Ag [Presence] in Unspecified specimen | Neisseria meningitidis Ag |
| 6492-3 | Neisseria meningitidis Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis Ag |
| 6508-6 | Neisseria meningitidis Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis Ag |
| 50607-1 | Neisseria meningitidis Ag panel in Unspecified specimen by Latex agglutination | Neisseria meningitidis Ag panel |
| 17327-8 | Neisseria meningitidis B Ab [Units/volume] in Serum | Neisseria meningitidis B Ab |
| 17328-6 | Neisseria meningitidis B Ag [Presence] in Urine by Latex agglutination | Neisseria meningitidis B Ag |
| 24017-6 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis B Ag |
| 24018-4 | Neisseria meningitidis B Ag [Presence] in Urine | Neisseria meningitidis B Ag |
| 30095-4 | Neisseria meningitidis B Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis B Ag |
| 31913-7 | Neisseria meningitidis B Ag [Presence] in Unspecified specimen | Neisseria meningitidis B Ag |
| 41503-4 | Neisseria meningitidis B Ag [Presence] in Body fluid | Neisseria meningitidis B Ag |
| 42370-7 | Neisseria meningitidis B Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis B Ag |
| 43430-8 | Neisseria meningitidis B Ag [Presence] in Serum | Neisseria meningitidis B Ag |
| 6496-4 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis B Ag |
| 6497-2 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis B Ag |
| 6498-0 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis B Ag |
| 19134-6 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 19260-9 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 31914-5 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 31915-2 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Unspecified specimen | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 32707-2 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Urine | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 33399-7 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Serum | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 33400-3 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Serum by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 33401-1 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Urine by Latex agglutination | Neisseria meningitidis B+Escherichia coli K1 Ag |
| 13272-0 | Neisseria meningitidis C Ab [Units/volume] in Serum | Neisseria meningitidis C Ab |
| 28547-8 | Neisseria meningitidis C IgG Ab [Mass/volume] in Serum by Immunoassay | Neisseria meningitidis C Ab.IgG |
| 31527-5 | Neisseria meningitidis C IgG Ab [Units/volume] in Serum | Neisseria meningitidis C Ab.IgG |
| 42985-2 | Neisseria meningitidis C IgG Ab [Mass/volume] in Serum | Neisseria meningitidis C Ab.IgG |
| 17329-4 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis C Ag |
| 30096-2 | Neisseria meningitidis C Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis C Ag |
| 31916-0 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis C Ag |
| 31917-8 | Neisseria meningitidis C Ag [Presence] in Unspecified specimen | Neisseria meningitidis C Ag |
| 42371-5 | Neisseria meningitidis C Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis C Ag |
| 6499-8 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis C Ag |
| 6500-3 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis C Ag |
| 6501-1 | Neisseria meningitidis C Ag [Presence] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis C Ag |
| 17325-2 | Neisseria meningitidis C+W135 Ag [Presence] in Urine | Neisseria meningitidis C+w135 Ag |
| 19022-3 | Neisseria meningitidis C+W135 Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis C+w135 Ag |
| 32800-5 | Neisseria meningitidis C+W135 Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis C+w135 Ag |
| 32841-9 | Neisseria meningitidis C+W135 Ag [Presence] in Unspecified specimen | Neisseria meningitidis C+w135 Ag |
| 42372-3 | Neisseria meningitidis D Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis D Ag |
| 49671-1 | Neisseria meningitidis DNA [Presence] in Unspecified specimen by Probe & target amplification method | Neisseria meningitidis DNA |
| 53606-0 | Neisseria meningitidis DNA [Presence] in Blood by Probe & target amplification method | Neisseria meningitidis DNA |
| 17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum | Neisseria meningitidis polyvalent Ab |
| 17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis polyvalent Ag |
| 5029-4 | Neisseria meningitidis rRNA [Presence] in Unspecified specimen by DNA probe | Neisseria meningitidis rRNA |
| 6509-4 | Neisseria meningitidis rRNA [Presence] in Cerebral spinal fluid by DNA probe | Neisseria meningitidis rRNA |
| 49722-2 | Neisseria meningitidis type [Identifier] in Isolate by Agglutination | Neisseria meningitidis type |
| 39610-1 | Neisseria meningitidis w135 Ab [Mass/volume] in Serum | Neisseria meningitidis w135 Ab |
| 17333-6 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma by Latex agglutination | Neisseria meningitidis w135 Ag |
| 30097-0 | Neisseria meningitidis w135 Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis w135 Ag |
| 31918-6 | Neisseria meningitidis w135 Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis w135 Ag |
| 31919-4 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma | Neisseria meningitidis w135 Ag |
| 31920-2 | Neisseria meningitidis w135 Ag [Presence] in Unspecified specimen | Neisseria meningitidis w135 Ag |
| 42368-1 | Neisseria meningitidis w135 Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis w135 Ag |
| 6506-0 | Neisseria meningitidis w135 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis w135 Ag |
| 6507-8 | Neisseria meningitidis w135 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis w135 Ag |
| 42373-1 | Neisseria meningitidis X Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis X Ag |
| 22431-1 | Neisseria meningitidis Y Ab [Titer] in Unspecified specimen | Neisseria meningitidis Y Ab |
| 31528-3 | Neisseria meningitidis Y Ab [Units/volume] in Unspecified specimen | Neisseria meningitidis Y Ab |
| 39618-4 | Neisseria meningitidis Y Ab [Mass/volume] in Serum | Neisseria meningitidis Y Ab |
| 6502-9 | Neisseria meningitidis Y Ab [Titer] in Unspecified specimen by Immunofluorescence | Neisseria meningitidis Y Ab |
| 7972-3 | Neisseria meningitidis Y Ab [Presence] in Unspecified specimen | Neisseria meningitidis Y Ab |
| 17330-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid | Neisseria meningitidis Y Ag |
| 30098-8 | Neisseria meningitidis Y Ag [Presence] in Unspecified specimen by Latex agglutination | Neisseria meningitidis Y Ag |
| 31921-0 | Neisseria meningitidis Y Ag [Presence] in Unspecified specimen | Neisseria meningitidis Y Ag |
| 42374-9 | Neisseria meningitidis Y Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis Y Ag |
| 6503-7 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid by Immunoassay | Neisseria meningitidis Y Ag |
| 6504-5 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | Neisseria meningitidis Y Ag |
| 6505-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | Neisseria meningitidis Y Ag |
| 42375-6 | Neisseria meningitidis Z Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis Z Ag |
| 42376-4 | Neisseria meningitidis Z' Ag [Presence] in Isolate by Agglutination | Neisseria meningitidis Z' Ag |
| 43383-9 | Neisseria sp identified in Throat by Organism specific culture | Neisseria sp identified |
| 43384-7 | Neisseria sp identified in Urethra by Organism specific culture | Neisseria sp identified |
| 43385-4 | Neisseria sp identified in Cervix by Organism specific culture | Neisseria sp identified |
| 43386-2 | Neisseria sp identified in Anal by Organism specific culture | Neisseria sp identified |
| 43387-0 | Neisseria sp identified in Unspecified specimen by Organism specific culture | Neisseria sp identified |
| 29120-3 | Nelfinavir [Units/volume] in Serum or Plasma | Nelfinavir |
| 30280-2 | Nelfinavir [Susceptibility] by Phenotype method | Nelfinavir |
| 30294-3 | Nelfinavir [Susceptibility] by Genotype method | Nelfinavir |
| 30309-9 | Nelfinavir [Susceptibility] | Nelfinavir |
| 32647-0 | Nelfinavir [Mass/volume] in Serum or Plasma | Nelfinavir |
| 35113-0 | Nelfinavir M8 [Mass/volume] in Serum or Plasma | Nelfinavir M8 |
| 51923-1 | Nelfinavir [Mass/volume] in Serum or Plasma --peak | Nelfinavir^peak |
| 10995-9 | Neomycin [Mass/volume] in Serum or Plasma | Neomycin |
| 18953-0 | Neomycin [Susceptibility] | Neomycin |
| 25262-7 | Neomycin [Mass/volume] in Unspecified specimen | Neomycin |
| 354-1 | Neomycin [Susceptibility] by Minimum lethal concentration (MLC) | Neomycin |
| 355-8 | Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Neomycin |
| 356-6 | Neomycin [Susceptibility] by Disk diffusion (KB) | Neomycin |
| 357-4 | Neomycin [Susceptibility] by Serum bactericidal titer | Neomycin |
| 41705-5 | Neomycin [Susceptibility] by Gradient strip (E-test) | Neomycin |
| 50189-0 | Neonatal bilirubin panel [Mass/volume] in Serum or Plasma | Neonatal bilirubin panel |
| 29750-7 | Neonatal intensive care records | Neonatal intensive care records |
| 34146-1 | Neopterin [Molecules/volume] in Cerebral spinal fluid | Neopterin |
| 34908-4 | Neopterin [Mass/volume] in Serum or Plasma | Neopterin |
| 35259-1 | Neopterin [Mass or Molecules/volume] in Serum or Plasma | Neopterin |
| 3847-1 | Neopterin [Mass/volume] in Urine | Neopterin |
| 4346-3 | Neopterin [Mass] of Dose | Neopterin |
| 9740-2 | Neopterin [Molecules/volume] in Serum or Plasma | Neopterin |
| 32332-9 | Neopterin/Biopterin [Molecular ratio] in Urine | Neopterin/Biopterin |
| 17334-4 | Neopterin/Creatinine [Mass ratio] in Urine | Neopterin/Creatinine |
| 47711-7 | Neopterin/Creatinine [Molecular ratio] in Urine | Neopterin/Creatinine |
| 48874-2 | Neorickettsia sp [Presence] in Unspecified specimen by Organism specific culture | Neorickettsia sp |
| 15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay | Neospora caninum Ab |
| 20904-9 | Neospora caninum Ab [Presence] in Serum by Immunofluorescence | Neospora caninum Ab |
| 22432-9 | Neospora caninum Ab [Presence] in Serum | Neospora caninum Ab |
| 22433-7 | None | Neospora caninum Ab |
| 23756-0 | Neospora caninum Ab [Units/volume] in Serum by Immunoassay | Neospora caninum Ab |
| 23757-8 | Neospora caninum Ab [Titer] in Serum by Immunofluorescence | Neospora caninum Ab |
| 23758-6 | Neospora caninum Ab [Titer] in Serum | Neospora caninum Ab |
| 31529-1 | Neospora caninum Ab [Units/volume] in Serum | Neospora caninum Ab |
| 23759-4 | Neospora caninum Ag [Presence] in Tissue by Immune stain | Neospora caninum Ag |
| 23760-2 | Neospora caninum Ag [Presence] in Fixed tissue by Immune stain | Neospora caninum Ag |
| 17335-1 | Neostigmine [Mass/volume] in Serum or Plasma | Neostigmine |
| 35170-0 | Nervonate (C24:1) [Molecules/volume] in Serum or Plasma | Nervonate |
| 18954-8 | Netilmicin [Susceptibility] | Netilmicin |
| 25263-5 | Netilmicin [Mass/volume] in Unspecified specimen | Netilmicin |
| 358-2 | Netilmicin [Susceptibility] by Minimum lethal concentration (MLC) | Netilmicin |
| 359-0 | Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Netilmicin |
| 360-8 | Netilmicin [Susceptibility] by Disk diffusion (KB) | Netilmicin |
| 361-6 | Netilmicin [Susceptibility] by Serum bactericidal titer | Netilmicin |
| 4347-1 | Netilmicin [Mass] of Dose | Netilmicin |
| 47385-0 | Netilmicin [Mass/volume] in Serum or Plasma | Netilmicin |
| 7035-9 | Netilmicin [Susceptibility] by Gradient strip (E-test) | Netilmicin |
| 3848-9 | Netilmicin [Mass/volume] in Serum or Plasma --peak | Netilmicin^peak |
| 3849-7 | Netilmicin [Mass/volume] in Serum or Plasma --random | Netilmicin^random |
| 3850-5 | Netilmicin [Mass/volume] in Serum or Plasma --trough | Netilmicin^trough |
| 50327-6 | Neu-N Ag [Presence] in Tissue by Immune stain | Neu-N Ag |
| 48803-1 | Neural tube defect risk [Finding] in fetus | Neural tube defect risk |
| 49838-6 | Neural tube defect risk [Finding] in population | Neural tube defect risk |
| 49091-2 | Neural tube defect risk based on maternal age [Finding] in fetus | Neural tube defect risk based on maternal age |
| 49584-6 | Neural tube defect risk cutoff [Finding] in fetus | Neural tube defect risk cutoff |
| 28311-9 | None | Neuro-musculo-skeletal function.behavior |
| 28474-5 | None | Neuro-musculo-skeletal function.behavior |
| 46843-9 | None | Neuro-musculo-skeletal function.behavior |
| 28312-7 | None | Neuro-musculo-skeletal function.knowledge |
| 28475-2 | None | Neuro-musculo-skeletal function.knowledge |
| 46844-7 | None | Neuro-musculo-skeletal function.knowledge |
| 28313-5 | None | Neuro-musculo-skeletal function.status |
| 28476-0 | None | Neuro-musculo-skeletal function.status |
| 46845-4 | None | Neuro-musculo-skeletal function.status |
| 47034-4 | Neurofilament Ag [Presence] in Tissue by Immune stain | Neurofilament Ag |
| 21417-1 | Neurokinin A [Units/volume] in Serum or Plasma | Neurokinin A |
| 49728-9 | Neurokinin A [Mass/volume] in Serum or Plasma | Neurokinin A |
| 39262-1 | None | Neurologic screen assessment |
| 39199-5 | None | Neurologic screen finding recency |
| 39198-7 | None | Neurologic screen follow-up status |
| 39197-9 | None | Neurologic screen results indicator |
| 46023-8 | None | Neurological diseases or conditions |
| 27897-8 | Neuromuscular electrophysiology studies (set) | Neuromuscular electrophysiology studies |
| 43638-6 | Neuromyelitis optica IgG Ab [Presence] in Serum or Plasma | Neuromyelitis optica Ab.IgG |
| 43752-5 | Neuromyelitis optica IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence | Neuromyelitis optica Ab.IgG |
| 44794-6 | Neuromyelitis optica IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | Neuromyelitis optica Ab.IgG |
| 46718-3 | Neuromyelitis optica IgG Ab [Presence] in Cerebral spinal fluid | Neuromyelitis optica Ab.IgG |
| 17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence | Neuronal Ab |
| 17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Neuronal Ab |
| 17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence | Neuronal Ab |
| 17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | Neuronal Ab |
| 31530-9 | Neuronal Ab [Units/volume] in Cerebral spinal fluid | Neuronal Ab |
| 31531-7 | Neuronal Ab [Presence] in Cerebral spinal fluid | Neuronal Ab |
| 31532-5 | Neuronal Ab [Units/volume] in Serum | Neuronal Ab |
| 31533-3 | Neuronal Ab [Presence] in Serum | Neuronal Ab |
| 32853-4 | Neuronal Ab [Units/volume] in Serum by Immunoassay | Neuronal Ab |
| 17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay | Neuronal Ab.IgG |
| 31534-1 | Neuronal IgG Ab [Presence] in Body fluid | Neuronal Ab.IgG |
| 33418-5 | Neuronal IgG Ab [Presence] in Serum | Neuronal Ab.IgG |
| 11088-2 | Neuronal nuclear Ab [Presence] in Serum | Neuronal nuclear Ab |
| 11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid | Neuronal nuclear Ab |
| 14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear Ab |
| 15398-1 | Neuronal nuclear Ab [Titer] in Serum | Neuronal nuclear Ab |
| 16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear Ab |
| 17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear Ab |
| 19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot (IB) | Neuronal nuclear Ab |
| 31535-8 | Neuronal nuclear Ab [Units/volume] in Serum | Neuronal nuclear Ab |
| 33600-8 | Neuronal nuclear Ab [Units/volume] in Serum by Immunofluorescence | Neuronal nuclear Ab |
| 35278-1 | Neuronal nuclear Ab [Presence] in Serum by Immunoblot (IB) | Neuronal nuclear Ab |
| 49738-8 | Neuronal nuclear Ab [Presence] in Serum by Immunofluorescence | Neuronal nuclear Ab |
| 15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence | Neuronal nuclear Ab.IgG |
| 31536-6 | Neuronal nuclear IgG Ab [Units/volume] in Serum | Neuronal nuclear Ab.IgG |
| 33590-1 | Neuronal nuclear IgG Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear Ab.IgG |
| 33591-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) | Neuronal nuclear Ab.IgG |
| 44770-6 | Neuronal nuclear IgG Ab [Titer] in Serum by Immunofluorescence | Neuronal nuclear Ab.IgG |
| 48405-5 | Neuronal nuclear IgG Ab [Presence] in Serum by Immunofluorescence | Neuronal nuclear Ab.IgG |
| 12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum | Neuronal nuclear type 1 Ab |
| 13115-1 | None | Neuronal nuclear type 1 Ab |
| 13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum | Neuronal nuclear type 1 Ab |
| 24400-4 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear type 1 Ab |
| 24403-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot (IB) | Neuronal nuclear type 1 Ab |
| 31537-4 | Neuronal nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear type 1 Ab |
| 33615-6 | Neuronal nuclear type 1 Ab [Presence] in Serum | Neuronal nuclear type 1 Ab |
| 41769-1 | Neuronal nuclear type 1 Ab [Presence] in Serum by Immunoblot (IB) | Neuronal nuclear type 1 Ab |
| 44768-0 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear type 1 Ab |
| 44769-8 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | Neuronal nuclear type 1 Ab |
| 53711-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear type 1 Ab |
| 13114-4 | None | Neuronal nuclear type 2 Ab |
| 13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum | Neuronal nuclear type 2 Ab |
| 17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum | Neuronal nuclear type 2 Ab |
| 17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid | Neuronal nuclear type 2 Ab |
| 17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence | Neuronal nuclear type 2 Ab |
| 24401-2 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | Neuronal nuclear type 2 Ab |
| 24404-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot (IB) | Neuronal nuclear type 2 Ab |
| 31538-2 | Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid | Neuronal nuclear type 2 Ab |
| 31539-0 | Neuronal nuclear type 2 Ab [Presence] in Serum | Neuronal nuclear type 2 Ab |
| 33008-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunoblot (IB) | Neuronal nuclear type 2 Ab |
| 43187-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunofluorescence | Neuronal nuclear type 2 Ab |
| 43188-2 | Neuronal nuclear type 2 Ab [Titer] in Serum by Immunofluorescence | Neuronal nuclear type 2 Ab |
| 53712-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear type 2 Ab |
| 33924-2 | Neuronal nuclear type 3 Ab [Titer] in Serum | Neuronal nuclear type 3 Ab |
| 35144-5 | Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid | Neuronal nuclear type 3 Ab |
| 43102-3 | Neuronal nuclear type 3 Ab [Presence] in Serum | Neuronal nuclear type 3 Ab |
| 28560-1 | Neuronal thread protein [Mass/volume] in Cerebral spinal fluid | Neuronal thread protein |
| 49866-7 | Neuropeptide Y [Mass/volume] in Serum | Neuropeptide Y |
| 2654-2 | Neurophysin [Mass/volume] in Serum or Plasma | Neurophysin |
| 6187-9 | Neurospora sitophila IgE Ab [Units/volume] in Serum | Neurospora sitophila Ab.IgE |
| 25485-4 | Neurospora sitophila IgE Ab RAST class in Serum | Neurospora sitophila Ab.IgE.RAST class |
| 2655-9 | Neurotensin [Mass/volume] in Serum | Neurotensin |
| 17345-0 | None | Neutrophil Ab |
| 17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence | Neutrophil Ab |
| 17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence | Neutrophil Ab |
| 21418-9 | Neutrophil Ab [Presence] in Serum | Neutrophil Ab |
| 39587-1 | Neutrophil Ab [Presence] in Serum by Immunoassay | Neutrophil Ab |
| 41617-2 | Neutrophil Ab [Presence] in Serum by Flow cytometry (FC) | Neutrophil Ab |
| 45150-0 | Neutrophil Ab [Units/volume] in Serum by Immunoassay | Neutrophil Ab |
| 5171-4 | Neutrophil Ab [Units/volume] in Serum | Neutrophil Ab |
| 17348-4 | Neutrophil IgA Ab [Units/volume] in Serum | Neutrophil Ab.IgA |
| 17349-2 | Neutrophil IgG Ab [Units/volume] in Serum | Neutrophil Ab.IgG |
| 17350-0 | Neutrophil IgM Ab [Units/volume] in Serum | Neutrophil Ab.IgM |
| 24382-4 | Neutrophil associated Ab [Identifier] in Serum | Neutrophil associated Ab |
| 34971-2 | Neutrophil associated Ab [Presence] in Blood | Neutrophil associated Ab |
| 11567-5 | None | Neutrophil cytoplasmic Ab |
| 17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum | Neutrophil cytoplasmic Ab |
| 17352-6 | Neutrophil cytoplasmic Ab [interpretation] in Serum | Neutrophil cytoplasmic Ab |
| 21023-7 | Neutrophil cytoplasmic Ab [Titer] in Serum | Neutrophil cytoplasmic Ab |
| 35279-9 | Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab |
| 45151-8 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunoassay | Neutrophil cytoplasmic Ab |
| 5128-4 | Neutrophil cytoplasmic Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab |
| 51924-9 | Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab |
| 5262-1 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab |
| 21419-7 | Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab pattern |
| 49308-0 | Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence Narrative | Neutrophil cytoplasmic Ab pattern |
| 17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum | Neutrophil cytoplasmic Ab.atypical |
| 29641-8 | Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.atypical |
| 53012-1 | Neutrophil Cytoplasmic Ab atypical [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.atypical |
| 14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.classic |
| 17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.classic |
| 30538-3 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum | Neutrophil cytoplasmic Ab.classic |
| 32708-0 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum | Neutrophil cytoplasmic Ab.classic |
| 37992-5 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum by Immunoassay | Neutrophil cytoplasmic Ab.classic |
| 8084-6 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum | Neutrophil cytoplasmic Ab.classic |
| 29642-6 | Neutrophil cytoplasmic Ab.classic.atypical [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.classic.atypical |
| 17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum | Neutrophil cytoplasmic Ab.IgA |
| 18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab.IgA |
| 17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum | Neutrophil cytoplasmic Ab.IgG |
| 18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab.IgG |
| 29967-7 | Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.IgG |
| 17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum | Neutrophil cytoplasmic Ab.IgM |
| 18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum | Neutrophil cytoplasmic Ab.IgM |
| 14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear |
| 17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear |
| 30539-1 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum | Neutrophil cytoplasmic Ab.perinuclear |
| 32787-4 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum | Neutrophil cytoplasmic Ab.perinuclear |
| 37991-7 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum by Immunoassay | Neutrophil cytoplasmic Ab.perinuclear |
| 8085-3 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum | Neutrophil cytoplasmic Ab.perinuclear |
| 49503-6 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Titer] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear.atypical |
| 53029-5 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab.perinuclear.atypical |
| 30903-9 | Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC) | Neutrophil oxidative burst |
| 43292-2 | Neutrophil oxidative burst/100 cells in Blood | Neutrophil oxidative burst/100 cells |
| 16290-9 | Neutrophils [Presence] in Stool | Neutrophils |
| 17359-1 | Neutrophils [#/volume] in Semen by Manual count | Neutrophils |
| 26499-4 | Neutrophils [#/volume] in Blood | Neutrophils |
| 26500-9 | Neutrophils [#/volume] in Cerebral spinal fluid | Neutrophils |
| 26501-7 | Neutrophils [#/volume] in Pleural fluid | Neutrophils |
| 26502-5 | Neutrophils [#/volume] in Peritoneal fluid | Neutrophils |
| 26503-3 | Neutrophils [#/volume] in Semen | Neutrophils |
| 26504-1 | Neutrophils [#/volume] in Synovial fluid | Neutrophils |
| 30448-5 | Neutrophils [#/volume] in Urine | Neutrophils |
| 32709-8 | Neutrophils [#/volume] in Body fluid | Neutrophils |
| 38996-5 | Neutrophils [Presence] in Urine by Light microscopy | Neutrophils |
| 40566-2 | Neutrophils [#/volume] in Body fluid by Manual count | Neutrophils |
| 48048-3 | Neutrophils [Presence] in Nose by Wright stain | Neutrophils |
| 48050-9 | Neutrophils [Presence] in Stool by Wright stain | Neutrophils |
| 5906-3 | Neutrophils [#/volume] in Synovial fluid by Automated count | Neutrophils |
| 751-8 | Neutrophils [#/volume] in Blood by Automated count | Neutrophils |
| 752-6 | None | Neutrophils |
| 753-4 | Neutrophils [#/volume] in Blood by Manual count | Neutrophils |
| 754-2 | Neutrophils [#/volume] in Cerebral spinal fluid by Automated count | Neutrophils |
| 755-9 | Neutrophils [#/volume] in Cerebral spinal fluid by Manual count | Neutrophils |
| 756-7 | Neutrophils [#/volume] in Pleural fluid by Automated count | Neutrophils |
| 757-5 | Neutrophils [#/volume] in Pleural fluid by Manual count | Neutrophils |
| 758-3 | Neutrophils [#/volume] in Peritoneal fluid by Automated count | Neutrophils |
| 759-1 | Neutrophils [#/volume] in Peritoneal fluid by Manual count | Neutrophils |
| 760-9 | Neutrophils [#/volume] in Synovial fluid by Manual count | Neutrophils |
| 761-7 | Neutrophils [#/volume] in Urine by Automated count | Neutrophils |
| 762-5 | Neutrophils [#/volume] in Urine by Manual count | Neutrophils |
| 33215-5 | Neutrophils.agranular [Presence] in Blood by Light microscopy | Neutrophils.agranular |
| 26507-4 | Neutrophils.band form [#/volume] in Blood | Neutrophils.band form |
| 30229-9 | Neutrophils.band form [#/volume] in Blood by Automated count | Neutrophils.band form |
| 34524-9 | Neutrophils.band form [Presence] in Blood by Automated count | Neutrophils.band form |
| 35013-2 | Neutrophils.band form [#/volume] in Synovial fluid | Neutrophils.band form |
| 35014-0 | Neutrophils.band form [#/volume] in Body fluid | Neutrophils.band form |
| 35015-7 | Neutrophils.band form [#/volume] in Cerebral spinal fluid | Neutrophils.band form |
| 40572-0 | Neutrophils.band form [#/volume] in Body fluid by Manual count | Neutrophils.band form |
| 763-3 | Neutrophils.band form [#/volume] in Blood by Manual count | Neutrophils.band form |
| 11103-9 | Neutrophils.band form/100 cells in Bone marrow by Microscopy | Neutrophils.band form/100 cells |
| 12278-8 | Neutrophils.band form/100 leukocytes in Cerebral spinal fluid by Manual count | Neutrophils.band form/100 leukocytes |
| 13354-6 | Neutrophils.band form/100 leukocytes in Body fluid by Manual count | Neutrophils.band form/100 leukocytes |
| 26508-2 | Neutrophils.band form/100 leukocytes in Blood | Neutrophils.band form/100 leukocytes |
| 26509-0 | Neutrophils.band form/100 leukocytes in Cerebral spinal fluid | Neutrophils.band form/100 leukocytes |
| 26510-8 | Neutrophils.band form/100 leukocytes in Body fluid | Neutrophils.band form/100 leukocytes |
| 33361-7 | Neutrophils.band form/100 leukocytes in Synovial fluid | Neutrophils.band form/100 leukocytes |
| 33388-0 | Neutrophils.band form/100 leukocytes in Pericardial fluid | Neutrophils.band form/100 leukocytes |
| 35332-6 | Neutrophils.band form/100 leukocytes in Blood by Automated count | Neutrophils.band form/100 leukocytes |
| 764-1 | Neutrophils.band form/100 leukocytes in Blood by Manual count | Neutrophils.band form/100 leukocytes |
| 30449-3 | Neutrophils.hypersegmented [#/volume] in Blood | Neutrophils.hypersegmented |
| 34199-0 | Neutrophils.hypersegmented [Presence] in Blood by Automated count | Neutrophils.hypersegmented |
| 765-8 | Neutrophils.hypersegmented [Presence] in Blood by Light microscopy | Neutrophils.hypersegmented |
| 766-6 | Neutrophils.hypersegmented [#/volume] in Blood by Manual count | Neutrophils.hypersegmented |
| 30450-1 | Neutrophils.hypersegmented/100 leukocytes in Blood | Neutrophils.hypersegmented/100 leukocytes |
| 767-4 | Neutrophils.hypersegmented/100 leukocytes in Blood by Manual count | Neutrophils.hypersegmented/100 leukocytes |
| 40654-6 | Neutrophils.hypogranulated [Presence] in Blood by Light microscopy | Neutrophils.hypogranulated |
| 53797-7 | Neutrophils.immature/100 leukocytes in Blood | Neutrophils.immature/100 leukocytes |
| 30451-9 | Neutrophils.segmented [#/volume] in Blood | Neutrophils.segmented |
| 30452-7 | Neutrophils.segmented [#/volume] in Body fluid | Neutrophils.segmented |
| 35009-0 | Neutrophils.segmented [#/volume] in Synovial fluid | Neutrophils.segmented |
| 35010-8 | Neutrophils.segmented [#/volume] in Peritoneal fluid | Neutrophils.segmented |
| 35011-6 | Neutrophils.segmented [#/volume] in Cerebral spinal fluid | Neutrophils.segmented |
| 35012-4 | Neutrophils.segmented [#/volume] in Pleural fluid | Neutrophils.segmented |
| 6745-4 | Neutrophils.segmented [#/volume] in Body fluid by Manual count | Neutrophils.segmented |
| 768-2 | Neutrophils.segmented [#/volume] in Blood by Manual count | Neutrophils.segmented |
| 11128-6 | Neutrophils.segmented/100 cells in Bone marrow | Neutrophils.segmented/100 cells |
| 14107-7 | Neutrophils.segmented/100 leukocytes in Cerebral spinal fluid by Manual count | Neutrophils.segmented/100 leukocytes |
| 26505-8 | Neutrophils.segmented/100 leukocytes in Blood | Neutrophils.segmented/100 leukocytes |
| 26506-6 | Neutrophils.segmented/100 leukocytes in Cerebral spinal fluid | Neutrophils.segmented/100 leukocytes |
| 30230-7 | Neutrophils.segmented/100 leukocytes in Body fluid by Manual count | Neutrophils.segmented/100 leukocytes |
| 30453-5 | Neutrophils.segmented/100 leukocytes in Body fluid | Neutrophils.segmented/100 leukocytes |
| 32200-8 | Neutrophils.segmented/100 leukocytes in Blood by Automated count | Neutrophils.segmented/100 leukocytes |
| 33384-9 | Neutrophils.segmented/100 leukocytes in Peritoneal fluid | Neutrophils.segmented/100 leukocytes |
| 33385-6 | Neutrophils.segmented/100 leukocytes in Pleural fluid | Neutrophils.segmented/100 leukocytes |
| 33386-4 | Neutrophils.segmented/100 leukocytes in Synovial fluid | Neutrophils.segmented/100 leukocytes |
| 33387-2 | Neutrophils.segmented/100 leukocytes in Pericardial fluid | Neutrophils.segmented/100 leukocytes |
| 769-0 | Neutrophils.segmented/100 leukocytes in Blood by Manual count | Neutrophils.segmented/100 leukocytes |
| 18319-4 | Neutrophils.vacuolated [Presence] in Blood by Light microscopy | Neutrophils.vacuolated |
| 34473-9 | Neutrophils.vacuolated+Segmented [Presence] in Blood | Neutrophils.vacuolated+Segmented |
| 11115-3 | Neutrophils/100 cells in Bone marrow by Microscopy | Neutrophils/100 cells |
| 12238-2 | Neutrophils/100 leukocytes in Body fluid by Manual count | Neutrophils/100 leukocytes |
| 13352-0 | None | Neutrophils/100 leukocytes |
| 13516-0 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count | Neutrophils/100 leukocytes |
| 13597-0 | Neutrophils/100 leukocytes in Nose | Neutrophils/100 leukocytes |
| 13836-2 | Neutrophils/100 leukocytes in Peritoneal fluid by Manual count | Neutrophils/100 leukocytes |
| 14039-2 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy | Neutrophils/100 leukocytes |
| 14847-8 | Neutrophils/100 leukocytes in Pericardial fluid by Manual count | Neutrophils/100 leukocytes |
| 14848-6 | Neutrophils/100 leukocytes in Pleural fluid by Manual count | Neutrophils/100 leukocytes |
| 17836-8 | Neutrophils/100 leukocytes in Synovial fluid | Neutrophils/100 leukocytes |
| 23761-0 | Neutrophils/100 leukocytes in Blood by Manual count | Neutrophils/100 leukocytes |
| 26511-6 | Neutrophils/100 leukocytes in Blood | Neutrophils/100 leukocytes |
| 26512-4 | Neutrophils/100 leukocytes in Cerebral spinal fluid | Neutrophils/100 leukocytes |
| 26513-2 | Neutrophils/100 leukocytes in Body fluid | Neutrophils/100 leukocytes |
| 26514-0 | Neutrophils/100 leukocytes in Peritoneal fluid | Neutrophils/100 leukocytes |
| 27930-7 | Neutrophils/100 leukocytes in Bronchial specimen | Neutrophils/100 leukocytes |
| 27932-3 | Neutrophils/100 leukocytes in Sputum | Neutrophils/100 leukocytes |
| 30454-3 | Neutrophils/100 leukocytes in Pericardial fluid | Neutrophils/100 leukocytes |
| 30455-0 | Neutrophils/100 leukocytes in Pleural fluid | Neutrophils/100 leukocytes |
| 32804-7 | Neutrophils/100 leukocytes in Bronchial specimen by Manual count | Neutrophils/100 leukocytes |
| 40491-3 | Neutrophils/100 leukocytes in Synovial fluid by Manual count | Neutrophils/100 leukocytes |
| 40536-5 | Neutrophils/100 leukocytes in Peritoneal dialysis fluid by Manual count | Neutrophils/100 leukocytes |
| 53520-3 | Neutrophils/100 leukocytes in Dialysis fluid | Neutrophils/100 leukocytes |
| 770-8 | Neutrophils/100 leukocytes in Blood by Automated count | Neutrophils/100 leukocytes |
| 29121-1 | Nevirapine [Units/volume] in Serum or Plasma | Nevirapine |
| 30275-2 | Nevirapine [Susceptibility] by Phenotype method | Nevirapine |
| 30289-3 | Nevirapine [Susceptibility] by Genotype method | Nevirapine |
| 30311-5 | Nevirapine [Susceptibility] | Nevirapine |
| 32646-2 | Nevirapine [Mass/volume] in Serum or Plasma | Nevirapine |
| 51925-6 | Nevirapine [Mass/volume] in Serum or Plasma --peak | Nevirapine^peak |
| 18626-2 | Psychiatric rehabilitation treatment plan, new/revised | New &or revised |
| 27470-4 | Skilled nursing treatment plan, new/revised | New &or revised |
| 27474-6 | Alcohol-substance abuse rehabilitation treatment plan, new/revised | New &or revised |
| 27483-7 | Cardiac rehabilitation treatment plan, new/revised | New &or revised |
| 27597-4 | Occupational therapy treatment plan, new/revised | New &or revised |
| 27660-0 | Physical therapy treatment plan, new/revised | New &or revised |
| 27699-8 | Respiratory therapy treatment plan, new/revised | New &or revised |
| 27750-9 | Medical social services treatment plan, new/revised | New &or revised |
| 29162-5 | Speech therapy treatment plan, new/revised | New &or revised |
| 52136-9 | None | New &or revised |
| 48299-2 | New coccine triggered leukotriene release [Mass/volume] by Leukocytes | New coccine leukotriene release |
| 45834-9 | None | New medications |
| 16262-8 | Newberyite crystals [Presence] in Stone by Infrared spectroscopy | Newberyite crystals |
| 42842-5 | None | Newborn behavior alteration |
| 32416-0 | None | Newborn complication |
| 54111-0 | None | Newborn hearing loss panel |
| 54107-8 | None | Newborn hearing screen |
| 54108-6 | None | Newborn hearing screen |
| 54109-4 | None | Newborn hearing screen |
| 54110-2 | None | Newborn hearing screen |
| 54106-0 | None | Newborn hearing screen method |
| 32417-8 | None | Newborn ICU admission diagnosis |
| 35085-0 | Newborn screening panel in Blood dot (filter paper) by American College of Medical Genetics (ACMG) | Newborn screening panel |
| 54089-8 | Newborn screening panel by American Health Information Community (AHIC) | Newborn screening panel |
| 49544-0 | Newborn screening recommended follow-up [interpretation] | Newborn screening recommended follow-up |
| 18671-8 | Alcohol-substance abuse rehabilitation treatment plan, next plan of treatment text (narrative) | Next plan of treatment |
| 52105-4 | Alcohol-substance abuse rehabilitation treatment plan, next plan of treatment (narrative) | Next plan of treatment |
| 30909-6 | Alcohol-substance abuse rehabilitation treatment plan, next planned treatment end date | Next planned treatment end date |
| 30908-8 | Alcohol-substance abuse rehabilitation treatment plan, next planned treatment start date | Next planned treatment start date |
| 21717-4 | NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NF1 gene mutation analysis |
| 45331-6 | NF1 gene mutations found [Identifier] in Amniotic Fluid by Molecular genetics method Nominal | NF1 gene mutation analysis |
| 21718-2 | NF1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | NF1 gene mutations tested for |
| 45332-4 | NF2 gene mutations found [Identifier] in Amniotic Fluid by Molecular genetics method Nominal | NF2 gene mutation analysis |
| 10836-5 | Niacin [Mass/volume] in Blood | Niacin |
| 18244-4 | Niacin [Mass/volume] in Serum or Plasma | Niacin |
| 2656-7 | Niacin [Mass/time] in 24 hour Urine | Niacin |
| 34342-6 | Niacin [Molecules/volume] in Serum or Plasma | Niacin |
| 51986-8 | Nicardipine [Presence] in Serum or Plasma | Nicardipine |
| 12779-5 | Nickel [Mass/time] in Urine | Nickel |
| 12780-3 | Nickel [Mass/volume] in Red Blood Cells | Nickel |
| 13649-9 | Nickel [Mass/volume] in Water | Nickel |
| 14099-6 | Nickel [Mass/volume] in Urine | Nickel |
| 18245-1 | Nickel [Mass/volume] in Unspecified specimen | Nickel |
| 25169-4 | Nickel [Molecules/volume] in Blood | Nickel |
| 25486-2 | Nickel [Molecules/volume] in Serum or Plasma | Nickel |
| 25487-0 | Nickel [Molecules/time] in 24 hour Urine | Nickel |
| 25961-4 | Nickel [Molecules/volume] in 24 hour Urine | Nickel |
| 29936-2 | Nickel [Mass/volume] in 24 hour Urine | Nickel |
| 30933-6 | Nickel [Mass/volume] in unspecified time Urine | Nickel |
| 34343-4 | Nickel [Molecules/volume] in Urine | Nickel |
| 47123-5 | Nickel [Molecules/mass] in Hair | Nickel |
| 50886-1 | Nickel [Molecules/mass] in Tissue | Nickel |
| 50887-9 | Nickel [Molecules/volume] in Red Blood Cells | Nickel |
| 51200-4 | Nickel [Mass/volume] in Body fluid | Nickel |
| 5700-0 | Nickel [Mass/volume] in Blood | Nickel |
| 5701-8 | Nickel [Mass/mass] in Hair | Nickel |
| 5702-6 | Nickel [Mass/volume] in Serum or Plasma | Nickel |
| 5703-4 | Nickel [Mass/time] in 24 hour Stool | Nickel |
| 5704-2 | Nickel [Presence] in Urine | Nickel |
| 5705-9 | Nickel [Mass/time] in 24 hour Urine | Nickel |
| 8207-3 | Nickel [Mass/volume] in Saliva | Nickel |
| 8208-1 | None | Nickel |
| 13472-6 | Nickel/Creatinine [Mass ratio] in Urine | Nickel/Creatinine |
| 25962-2 | Nickel/Creatinine [Molecular ratio] in 24 hour Urine | Nickel/Creatinine |
| 42001-8 | Nickel/Creatinine [Mass ratio] in 24 hour Urine | Nickel/Creatinine |
| 52926-3 | Nickel/Creatinine [Molecular ratio] in Urine | Nickel/Creatinine |
| 52462-9 | None | Nickname |
| 3851-3 | Nicomorphine [Mass/volume] in Urine | Nicomorphine |
| 4348-9 | Nicomorphine [Mass] of Dose | Nicomorphine |
| 6859-3 | Tobacco IgE Ab [Units/volume] in Serum | Nicotiana tabacum Ab.IgE |
| 16056-4 | Tobacco IgE Ab RAST class in Serum | Nicotiana tabacum Ab.IgE.RAST class |
| 7739-6 | Tobacco IgG Ab [Units/volume] in Serum | Nicotiana tabacum Ab.IgG |
| 7740-4 | Tobacco triggered histamine release [Units/volume] in Blood | Nicotiana tabacum basophil bound Ab |
| 7741-2 | None | Nicotiana tabacum cigarette Ab.IgE |
| 16055-6 | None | Nicotiana tabacum cigarette Ab.IgE.RAST class |
| 17362-5 | Nicotinamide [Presence] in Urine | Nicotinamide |
| 25488-8 | Nicotinamide [Molecules/volume] in Serum or Plasma | Nicotinamide |
| 27339-1 | Nicotinamide [Presence] in Blood | Nicotinamide |
| 3852-1 | Nicotinamide [Mass/volume] in Urine | Nicotinamide |
| 4349-7 | Nicotinamide [Mass] of Dose | Nicotinamide |
| 12294-5 | Nicotine [Presence] in Urine | Nicotine |
| 3853-9 | Nicotine [Mass/volume] in Serum or Plasma | Nicotine |
| 3854-7 | Nicotine [Mass/volume] in Urine | Nicotine |
| 40385-7 | Nicotine [Presence] in Meconium | Nicotine |
| 40386-5 | Nicotine [Presence] in Hair | Nicotine |
| 40387-3 | Nicotine [Presence] in Gastric fluid | Nicotine |
| 43195-7 | Nicotine [Presence] in Urine by Confirm method | Nicotine |
| 4350-5 | Nicotine [Mass] of Dose | Nicotine |
| 43830-9 | Nicotine [Presence] in Unspecified specimen | Nicotine |
| 43125-4 | Nicotine & Metabolites panel [Mass/volume] in Urine | Nicotine & Metabolites panel |
| 28555-1 | Nicotine+Cotinine [Presence] in Urine by Confirm method | Nicotine+Cotinine |
| 43218-7 | Nicotine+Cotinine [Presence] in Urine | Nicotine+Cotinine |
| 42192-5 | Nidus [Presence] in Stone | Nidus |
| 43594-1 | Nidus [Mass] in Stone | Nidus |
| 9386-4 | Nifedipine [Mass/volume] in Serum or Plasma | Nifedipine |
| 28392-9 | None | Night sweats |
| 7525-9 | Nigrospora oryzae IgE Ab [Units/volume] in Serum | Nigrospora oryzae Ab.IgE |
| 7526-7 | Nigrospora sphaerica IgE Ab [Units/volume] in Serum | Nigrospora sphaerica Ab.IgE |
| 15873-3 | Nigrospora sphaerica IgE Ab RAST class in Serum | Nigrospora sphaerica Ab.IgE.RAST class |
| 3855-4 | Nikethamide [Presence] in Urine | Nikethamide |
| 3856-2 | Nikethamide [Mass/volume] in Urine | Nikethamide |
| 3857-0 | Nikethamide [Mass/time] in 24 hour Urine | Nikethamide |
| 4351-3 | Nikethamide [Mass] of Dose | Nikethamide |
| 38907-2 | NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NIPA1 gene mutation analysis |
| 40428-5 | NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NIPBL gene mutation analysis |
| 41078-7 | NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NIPBL gene mutation analysis |
| 10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain | Nissel.microscopic observation |
| 12538-5 | Nitrate [Mass/volume] in Blood | Nitrate |
| 21420-5 | Nitrate [Mass/volume] in Urine | Nitrate |
| 32030-9 | Nitrate [Presence] in Urine | Nitrate |
| 9480-5 | Nitrate [Mass/volume] in Water | Nitrate |
| 23762-8 | Nitrate+Nitrite [Mass/volume] in Unspecified specimen | Nitrate+Nitrite |
| 14849-4 | Nitrazepam [Molecules/volume] in Serum or Plasma | Nitrazepam |
| 14850-2 | Nitrazepam [Molecules/volume] in Urine | Nitrazepam |
| 17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirm method | Nitrazepam |
| 19620-4 | Nitrazepam [Presence] in Urine by Screen method | Nitrazepam |
| 19621-2 | Nitrazepam [Presence] in Urine by Confirm method | Nitrazepam |
| 20552-6 | Nitrazepam [Mass/volume] in Urine by Confirm method | Nitrazepam |
| 3858-8 | Nitrazepam [Mass/volume] in Serum or Plasma | Nitrazepam |
| 3859-6 | Nitrazepam [Mass/volume] in Urine | Nitrazepam |
| 4352-1 | Nitrazepam [Mass] of Dose | Nitrazepam |
| 19622-0 | Nitrazepam cutoff [Mass/volume] in Urine for Screen method | Nitrazepam cutoff |
| 19623-8 | Nitrazepam cutoff [Mass/volume] in Urine for Confirm method | Nitrazepam cutoff |
| 13616-8 | Nitrite [Mass/volume] in Water | Nitrite |
| 18370-7 | Nitrite [Mass/volume] in Blood | Nitrite |
| 20407-3 | Nitrite [Mass/volume] in Urine by Test strip | Nitrite |
| 2657-5 | Nitrite [Mass/volume] in Urine | Nitrite |
| 32710-6 | Nitrite [Presence] in Urine | Nitrite |
| 50558-6 | Nitrite [Presence] in Urine by Automated test strip | Nitrite |
| 5802-4 | Nitrite [Presence] in Urine by Test strip | Nitrite |
| 38710-0 | Nitrobenzene [Mass/volume] in Air | Nitrobenzene |
| 32631-4 | Nitroblue Tetrazolium Test (NBT) [Presence] in Blood | Nitroblue tetrazolium test |
| 50609-7 | Nitroblue Tetrazolium Test (NBT) [Units/volume] in Blood | Nitroblue tetrazolium test |
| 18955-5 | Nitrofurantoin [Susceptibility] | Nitrofurantoin |
| 362-4 | Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC) | Nitrofurantoin |
| 363-2 | Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nitrofurantoin |
| 364-0 | Nitrofurantoin [Susceptibility] by Disk diffusion (KB) | Nitrofurantoin |
| 365-7 | Nitrofurantoin [Susceptibility] by Serum bactericidal titer | Nitrofurantoin |
| 3860-4 | Nitrofurantoin [Mass/volume] in Serum or Plasma | Nitrofurantoin |
| 4353-9 | Nitrofurantoin [Mass] of Dose | Nitrofurantoin |
| 7036-7 | Nitrofurantoin [Susceptibility] by Gradient strip (E-test) | Nitrofurantoin |
| 16141-4 | Nitrogen [Mass/time] in 24 hour Stool | Nitrogen |
| 18246-9 | Nitrogen [Mass/volume] in Stool | Nitrogen |
| 18247-7 | Nitrogen [Mass/volume] in Dialysis fluid | Nitrogen |
| 2658-3 | Nitrogen [Mass/volume] in Exhaled gas | Nitrogen |
| 2659-1 | None | Nitrogen |
| 2660-9 | Nitrogen [Mass/time] in 24 hour Urine | Nitrogen |
| 2664-1 | None | Nitrogen |
| 2665-8 | Nitrogen [Mass/time] in Urine | Nitrogen |
| 40388-1 | Nitrogen [Molecules/time] in 24 hour Urine | Nitrogen |
| 47712-5 | Nitrogen [Presence] in Sweat | Nitrogen |
| 50888-7 | Nitrogen [Molecules/time] in Body fluid | Nitrogen |
| 50889-5 | Nitrogen [Molecules/volume] in 24 hour Urine | Nitrogen |
| 53142-6 | Nitrogen [Molecules/time] in 24 hour Stool | Nitrogen |
| 53554-2 | Nitrogen [Mass/volume] in Air | Nitrogen |
| 2661-7 | Nitrogen.nonprotein [Presence] in Blood | Nitrogen.nonprotein |
| 2662-5 | Nitrogen.nonprotein [Mass/volume] in Blood | Nitrogen.nonprotein |
| 2663-3 | Nitrogen.nonprotein [Mass/volume] in Serum or Plasma | Nitrogen.nonprotein |
| 53091-5 | Nitrogen.nonprotein [Molecules/volume] in Serum or Plasma | Nitrogen.nonprotein |
| 12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma | Nitroglycerin |
| 13016-1 | Nitrophenol [Units/volume] in Blood | Nitrophenol |
| 17364-1 | Nitrophenol [Presence] in Urine | Nitrophenol |
| 17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma | Nitroprusside |
| 32548-0 | Nitroprusside reacting substances [Presence] in Urine | Nitroprusside reacting substances |
| 13892-5 | Nitrosonaphthol [Presence] in Urine | Nitrosonaphthol |
| 25608-1 | Nitroxoline [Susceptibility] | Nitroxoline |
| 25723-8 | Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) | Nitroxoline |
| 32382-4 | None | Nitroxoline |
| 17366-6 | Nizatidine [Mass/volume] in Serum or Plasma | Nizatidine |
| 47035-1 | NKI/C3 Ag [Presence] in Tissue by Immune stain | NKI-C3 Ag |
| 52834-9 | None | NMMDS nursing delivery unit or service panel |
| 52826-5 | None | NMMDS panel |
| 53410-7 | None | No change notification |
| 25060-5 | None | No charge |
| 45502-2 | None | No communication device |
| 46677-1 | None | No communicative limitations |
| 28162-6 | None | No energy to fight back |
| 46644-1 | None | No exertional limitations |
| 28528-8 | None | No good church experience |
| 46661-5 | None | No manipulative limitations |
| 45421-5 | None | No mental retardation and developmental disabilities |
| 45546-9 | None | No mode of transfer |
| 45540-2 | None | No modes of locomotion |
| 46652-4 | None | No postural limitations |
| 28532-0 | None | No purpose in life |
| 45583-2 | None | No unsettled relationships |
| 45514-7 | None | No visual limitations |
| 46668-0 | None | No visual limitations |
| 5263-9 | Nocardia sp Ab [Units/volume] in Serum | Nocardia sp Ab |
| 9569-5 | Nocardia sp IgG Ab [Units/volume] in Serum | Nocardia sp Ab.IgG |
| 14226-5 | Nocardia sp identified in Isolate by Organism specific culture | Nocardia sp identified |
| 43365-6 | Nocardia sp identified in Unspecified specimen by Organism specific culture | Nocardia sp identified |
| 46686-2 | None | Noise |
| 17367-4 | Nomifensine [Mass/volume] in Serum or Plasma | Nomifensine |
| 21942-8 | None | Non cancer directed surgery summary |
| 52072-6 | Non-Emergency Transportation | Non-emergency transportation attachment |
| 53246-5 | None | Non-medical services attachment |
| 53405-7 | None | Non-standardized allergenic label |
| 53207-7 | Nonanoylcarnitine (C9) [Molecules/volume] in Blood dot (filter paper) | Nonanoylcarnitine (C9) |
| 43680-8 | None | Nonclinical toxicology section |
| 28176-6 | None | Noncompliance |
| 32879-9 | None | Noncompliance with dental treatment |
| 28177-4 | None | Noncompliance with diagnostic test |
| 28178-2 | None | Noncompliance with dietary regimen |
| 28523-9 | None | Noncompliance with fluid volume |
| 28524-7 | None | Noncompliance with medication regimen |
| 28179-0 | None | Noncompliance with safety precautions |
| 28180-8 | None | Noncompliance with therapeutic regimen |
| 45445-4 | None | None of the listed additional ADL patterns |
| 45435-5 | None | None of the listed cycle of daily events |
| 45679-8 | None | None of the listed diseases or conditions |
| 45439-7 | None | None of the listed eating patterns |
| 45451-2 | None | None of the listed involvement patterns |
| 45417-3 | None | None of the listed prior residential settings |
| 35007-4 | Nonhematic cells [#/volume] in Cerebral spinal fluid | Nonhematic cells |
| 35008-2 | Nonhematic cells [#/volume] in Body fluid | Nonhematic cells |
| 13525-1 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count | Nonhematic cells/100 leukocytes |
| 13526-9 | Nonhematic cells/100 leukocytes in Body fluid by Manual count | Nonhematic cells/100 leukocytes |
| 30456-8 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid | Nonhematic cells/100 leukocytes |
| 30457-6 | Nonhematic cells/100 leukocytes in Body fluid | Nonhematic cells/100 leukocytes |
| 34078-6 | None | Nonteratogenic effects section |
| 54003-9 | NOR-90 Ab [Presence] in Serum by Immunofluorescence | NOR-90 Ab |
| 54004-7 | NOR-90 Ab [Titer] in Serum by Immunofluorescence | NOR-90 Ab |
| 10532-0 | None | Noramiodarone |
| 12709-2 | Norastemizole [Mass/volume] in Serum or Plasma | Norastemizole |
| 49751-1 | Norbuprenorphine [Mass/volume] in Urine by Confirm method | Norbuprenorphine |
| 49753-7 | Norbuprenorphine [Mass/volume] in Urine | Norbuprenorphine |
| 53880-1 | Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirm method | Norbuprenorphine |
| 53881-9 | Norbuprenorphine [Mass/volume] in Serum or Plasma | Norbuprenorphine |
| 12373-7 | None | Norchlordiazepoxide |
| 13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma | Norchlordiazepoxide |
| 27036-3 | Norchlordiazepoxide [Mass/volume] in Urine | Norchlordiazepoxide |
| 33301-3 | Norchlordiazepoxide [Presence] in Urine by Screen method | Norchlordiazepoxide |
| 9776-6 | Norchlordiazepoxide [Mass/volume] in Serum or Plasma | Norchlordiazepoxide |
| 26040-6 | Norcitalopram [Molecules/volume] in Serum or Plasma | Norcitalopram |
| 35106-4 | Norcitalopram [Mass/volume] in Serum or Plasma | Norcitalopram |
| 14693-6 | Norclobazam [Molecules/volume] in Serum or Plasma | Norclobazam |
| 35107-2 | Norclobazam [Mass/volume] in Serum or Plasma | Norclobazam |
| 13570-7 | Norclomipramine [Presence] in Serum or Plasma | Norclomipramine |
| 14694-4 | Norclomipramine [Molecules/volume] in Serum or Plasma | Norclomipramine |
| 18470-5 | Norclomipramine [Mass/volume] in Urine | Norclomipramine |
| 3536-0 | Norclomipramine [Mass/volume] in Serum or Plasma | Norclomipramine |
| 35621-2 | Norclomipramine [Mass/volume] in Serum or Plasma by Screen method | Norclomipramine |
| 10992-6 | Norclozapine [Mass/volume] in Serum or Plasma | Norclozapine |
| 12376-0 | None | Norclozapine |
| 13571-5 | Norclozapine [Presence] in Serum or Plasma | Norclozapine |
| 14851-0 | Norclozapine [Molecules/volume] in Serum or Plasma | Norclozapine |
| 50890-3 | Norclozapine [Molecules/volume] in Urine | Norclozapine |
| 49829-5 | Norcodeine [Mass/volume] in Urine | Norcodeine |
| 49830-3 | Norcodeine [Mass/volume] in Serum or Plasma | Norcodeine |
| 13572-3 | Nordiazepam [Presence] in Serum or Plasma | Nordiazepam |
| 15372-6 | Nordiazepam [Mass/volume] in Urine | Nordiazepam |
| 16202-4 | Nordiazepam [Presence] in Urine by Confirm method | Nordiazepam |
| 16228-9 | Nordiazepam [Mass/volume] in Urine by Confirm method | Nordiazepam |
| 16743-7 | None | Nordiazepam |
| 16744-5 | None | Nordiazepam |
| 18248-5 | Nordiazepam [Mass/volume] in Stool | Nordiazepam |
| 19624-6 | Nordiazepam [Presence] in Urine by Screen method | Nordiazepam |
| 26021-6 | Nordiazepam [Molecules/volume] in Serum or Plasma | Nordiazepam |
| 26816-9 | Nordiazepam [Mass/volume] in Vitreous fluid | Nordiazepam |
| 26840-9 | Nordiazepam [Mass/mass] in Hair | Nordiazepam |
| 26891-2 | Nordiazepam [Mass/mass] in Meconium | Nordiazepam |
| 27239-3 | Nordiazepam [Mass/mass] in Stool | Nordiazepam |
| 29385-2 | Nordiazepam [Mass/volume] in Gastric fluid | Nordiazepam |
| 3537-8 | Nordiazepam [Mass/volume] in Serum or Plasma | Nordiazepam |
| 35622-0 | Nordiazepam [Mass/volume] in Serum or Plasma by Screen method | Nordiazepam |
| 3861-2 | Nordiazepam [Presence] in Urine | Nordiazepam |
| 4213-5 | Nordiazepam [Mass] of Dose | Nordiazepam |
| 4354-7 | None | Nordiazepam |
| 48959-1 | Nordiazepam [Mass/volume] in Unspecified specimen | Nordiazepam |
| 19626-1 | Nordiazepam cutoff [Mass/volume] in Urine for Screen method | Nordiazepam cutoff |
| 19627-9 | Nordiazepam cutoff [Mass/volume] in Urine for Confirm method | Nordiazepam cutoff |
| 35114-8 | Nordothiepin [Mass/volume] in Serum or Plasma | Nordothiepin |
| 12386-9 | Nordoxepin [Mass/volume] in Urine | Nordoxepin |
| 13573-1 | Nordoxepin [Presence] in Serum or Plasma | Nordoxepin |
| 14695-1 | Nordoxepin [Molecules/volume] in Serum or Plasma | Nordoxepin |
| 29411-6 | Nordoxepin [Mass/volume] in Gastric fluid | Nordoxepin |
| 35623-8 | Nordoxepin [Mass/volume] in Serum or Plasma by Screen method | Nordoxepin |
| 3862-0 | Nordoxepin [Mass/volume] in Serum or Plasma | Nordoxepin |
| 4210-1 | Nordoxepin [Mass] of Dose | Nordoxepin |
| 4355-4 | None | Nordoxepin |
| 14852-8 | Norepinephrine [Molecules/volume] in Plasma | Norepinephrine |
| 14853-6 | Norepinephrine [Molecules/volume] in Urine | Norepinephrine |
| 14854-4 | Norepinephrine [Molecules/time] in 24 hour Urine | Norepinephrine |
| 25963-0 | Norepinephrine [Molecules/volume] in 24 hour Urine | Norepinephrine |
| 2666-6 | Norepinephrine [Mass/volume] in Plasma | Norepinephrine |
| 2667-4 | Norepinephrine [Mass/volume] in Urine | Norepinephrine |
| 2668-2 | Norepinephrine [Mass/time] in 24 hour Urine | Norepinephrine |
| 27221-1 | Norepinephrine [Mass/volume] in 24 hour Urine | Norepinephrine |
| 4356-2 | Norepinephrine [Mass] of Dose | Norepinephrine |
| 13782-8 | Norepinephrine/Creatinine [Mass ratio] in Urine | Norepinephrine/Creatinine |
| 24523-3 | Norepinephrine/Creatinine [Molecular ratio] in Urine | Norepinephrine/Creatinine |
| 27977-8 | Norepinephrine/Creatinine [Molecular ratio] in 24 hour Urine | Norepinephrine/Creatinine |
| 32549-8 | Norepinephrine/Creatinine [Molecular ratio] in unspecified time Urine | Norepinephrine/Creatinine |
| 44341-6 | Norepinephrine/Creatinine [Mass ratio] in 24 hour Urine | Norepinephrine/Creatinine |
| 1602-2 | Norepinephrine [Mass/volume] in Plasma --10 minutes post standing | Norepinephrine^10M post standing |
| 47155-7 | Norepinephrine [Molecules/volume] in Plasma --10 minutes post standing | Norepinephrine^10M post standing |
| 1603-0 | Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO | Norepinephrine^1H post 300 ug clonidine PO |
| 47156-5 | Norepinephrine [Molecules/volume] in Plasma --1 hour post 300 ug clonidine PO | Norepinephrine^1H post 300 ug clonidine PO |
| 12525-2 | Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge | Norepinephrine^1H post XXX challenge |
| 47157-3 | Norepinephrine [Molecules/volume] in Plasma --1 hour post XXX challenge | Norepinephrine^1H post XXX challenge |
| 1604-8 | Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO | Norepinephrine^2H post 300 ug clonidine PO |
| 47158-1 | Norepinephrine [Molecules/volume] in Plasma --2 hours post 300 ug clonidine PO | Norepinephrine^2H post 300 ug clonidine PO |
| 12526-0 | Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge | Norepinephrine^2H post XXX challenge |
| 47159-9 | Norepinephrine [Molecules/volume] in Plasma --2 hours post XXX challenge | Norepinephrine^2H post XXX challenge |
| 13426-2 | Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
| 17369-0 | Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
| 47160-7 | Norepinephrine [Molecules/volume] in Plasma --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
| 47161-5 | Norepinephrine [Molecules/volume] in Urine --2nd specimen post XXX challenge | Norepinephrine^2nd specimen post XXX challenge |
| 1605-5 | Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO | Norepinephrine^3H post 300 ug clonidine PO |
| 47162-3 | Norepinephrine [Molecules/volume] in Plasma --3 hours post 300 ug clonidine PO | Norepinephrine^3H post 300 ug clonidine PO |
| 12527-8 | Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge | Norepinephrine^3H post XXX challenge |
| 47163-1 | Norepinephrine [Molecules/volume] in Plasma --3 hours post XXX challenge | Norepinephrine^3H post XXX challenge |
| 13427-0 | Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
| 17370-8 | Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
| 47164-9 | Norepinephrine [Molecules/volume] in Plasma --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
| 47165-6 | Norepinephrine [Molecules/volume] in Urine --3rd specimen post XXX challenge | Norepinephrine^3rd specimen post XXX challenge |
| 12528-6 | Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge | Norepinephrine^4H post XXX challenge |
| 47166-4 | Norepinephrine [Molecules/volume] in Plasma --4 hours post XXX challenge | Norepinephrine^4H post XXX challenge |
| 13428-8 | Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
| 17371-6 | Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
| 47167-2 | Norepinephrine [Molecules/volume] in Plasma --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
| 47168-0 | Norepinephrine [Molecules/volume] in Urine --4th specimen post XXX challenge | Norepinephrine^4th specimen post XXX challenge |
| 13429-6 | Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
| 17372-4 | Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
| 47169-8 | Norepinephrine [Molecules/volume] in Plasma --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
| 47170-6 | Norepinephrine [Molecules/volume] in Urine --5th specimen post XXX challenge | Norepinephrine^5th specimen post XXX challenge |
| 13430-4 | Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
| 17373-2 | Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
| 47171-4 | Norepinephrine [Molecules/volume] in Plasma --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
| 47172-2 | Norepinephrine [Molecules/volume] in Urine --6th specimen post XXX challenge | Norepinephrine^6th specimen post XXX challenge |
| 13431-2 | Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
| 17374-0 | Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
| 47174-8 | Norepinephrine [Molecules/volume] in Urine --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
| 49009-4 | Norepinephrine [Molecules/volume] in Plasma --7th specimen post XXX challenge | Norepinephrine^7th specimen post XXX challenge |
| 1606-3 | Norepinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO | Norepinephrine^pre 300 ug clonidine PO |
| 47175-5 | Norepinephrine [Molecules/volume] in Plasma --pre 300 ug clonidine PO | Norepinephrine^pre 300 ug clonidine PO |
| 51429-9 | Norepinephrine [Molecules/volume] in Serum or Plasma --pre/post XXX challenge | Norepinephrine^pre/post XXX challenge |
| 17368-2 | Norepinephrine [Mass/volume] in Plasma --standing | Norepinephrine^standing |
| 33843-4 | Norepinephrine [Molecules/volume] in Plasma --standing | Norepinephrine^standing |
| 1601-4 | Norepinephrine [Mass/volume] in Plasma --supine | Norepinephrine^supine |
| 33844-2 | Norepinephrine [Molecules/volume] in Plasma --supine | Norepinephrine^supine |
| 3863-8 | Norethandrolone [Presence] in Urine | Norethandrolone |
| 3864-6 | Norethandrolone [Mass/volume] in Urine | Norethandrolone |
| 3865-3 | Norethandrolone [Mass/time] in 24 hour Urine | Norethandrolone |
| 4357-0 | Norethandrolone [Mass] of Dose | Norethandrolone |
| 13907-1 | Norethindrone [Mass/volume] in Serum or Plasma | Norethindrone |
| 49756-0 | Norethindrone [Mass/volume] in Urine | Norethindrone |
| 3866-1 | Norfenefrine [Mass/volume] in Urine | Norfenefrine |
| 4358-8 | Norfenefrine [Mass] of Dose | Norfenefrine |
| 12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma | Norfenfluramine |
| 11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma | Norfentanyl |
| 11075-9 | Norfentanyl [Mass/volume] in Urine | Norfentanyl |
| 43199-9 | Norfentanyl [Presence] in Urine | Norfentanyl |
| 43200-5 | Norfentanyl [Presence] in Urine by Confirm method | Norfentanyl |
| 18956-3 | Norfloxacin [Susceptibility] | Norfloxacin |
| 366-5 | Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Norfloxacin |
| 367-3 | Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Norfloxacin |
| 368-1 | Norfloxacin [Susceptibility] by Disk diffusion (KB) | Norfloxacin |
| 369-9 | Norfloxacin [Susceptibility] by Serum bactericidal titer | Norfloxacin |
| 3867-9 | Norfloxacin [Mass/volume] in Serum or Plasma | Norfloxacin |
| 41504-2 | Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Norfloxacin |
| 4359-6 | Norfloxacin [Mass] of Dose | Norfloxacin |
| 7037-5 | Norfloxacin [Susceptibility] by Gradient strip (E-test) | Norfloxacin |
| 17375-7 | Norflunitrazepam [Mass/volume] in Blood | Norflunitrazepam |
| 26039-8 | Norflunitrazepam [Molecules/volume] in Serum or Plasma | Norflunitrazepam |
| 27083-5 | Norflunitrazepam [Mass/volume] in Urine | Norflunitrazepam |
| 32650-4 | Norflunitrazepam [Mass/volume] in Serum or Plasma | Norflunitrazepam |
| 12445-3 | Norfluoxetine [Mass/volume] in Urine | Norfluoxetine |
| 13574-9 | Norfluoxetine [Presence] in Serum or Plasma | Norfluoxetine |
| 14855-1 | Norfluoxetine [Molecules/volume] in Serum or Plasma | Norfluoxetine |
| 19628-7 | Norfluoxetine [Presence] in Urine by Screen method | Norfluoxetine |
| 19629-5 | Norfluoxetine [Presence] in Urine by Confirm method | Norfluoxetine |
| 20553-4 | Norfluoxetine [Mass/volume] in Urine by Confirm method | Norfluoxetine |
| 35624-6 | Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method | Norfluoxetine |
| 3868-7 | Norfluoxetine [Mass/volume] in Serum or Plasma | Norfluoxetine |
| 19630-3 | Norfluoxetine cutoff [Mass/volume] in Urine for Screen method | Norfluoxetine cutoff |
| 19631-1 | Norfluoxetine cutoff [Mass/volume] in Urine for Confirm method | Norfluoxetine cutoff |
| 18322-8 | Norketamine [Mass/volume] in Urine | Norketamine |
| 21421-3 | Norketamine [Mass/volume] in Serum or Plasma | Norketamine |
| 13575-6 | Normaprotiline [Presence] in Serum or Plasma | Normaprotiline |
| 35108-0 | Normaprotiline [Mass/volume] in Serum or Plasma | Normaprotiline |
| 10544-5 | Normeperidine [Presence] in Serum or Plasma | Normeperidine |
| 10996-7 | Normeperidine [Mass/volume] in Serum or Plasma | Normeperidine |
| 27920-8 | Normeperidine [Presence] in Urine | Normeperidine |
| 35625-3 | Normeperidine [Mass/volume] in Serum or Plasma by Screen method | Normeperidine |
| 3869-5 | Normeperidine [Mass/volume] in Urine | Normeperidine |
| 10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma | Normephenytoin |
| 26041-4 | Normephenytoin [Molecules/volume] in Serum or Plasma | Normephenytoin |
| 15083-9 | Normetanephrine [Molecules/time] in 24 hour Urine | Normetanephrine |
| 21422-1 | Normetanephrine [Mass/volume] in 24 hour Urine | Normetanephrine |
| 25489-6 | Normetanephrine [Molecules/volume] in Serum or Plasma | Normetanephrine |
| 25964-8 | Normetanephrine [Molecules/volume] in 24 hour Urine | Normetanephrine |
| 2669-0 | Normetanephrine [Mass/volume] in Serum or Plasma | Normetanephrine |
| 2670-8 | Normetanephrine [Mass/volume] in Urine | Normetanephrine |
| 2671-6 | Normetanephrine [Mass/time] in 24 hour Urine | Normetanephrine |
| 34347-5 | Normetanephrine [Molecules/volume] in Urine | Normetanephrine |
| 4360-4 | Normetanephrine [Mass] of Dose | Normetanephrine |
| 40851-8 | Normetanephrine Free [Molecules/volume] in Serum or Plasma | Normetanephrine.free |
| 13783-6 | Normetanephrine/Creatinine [Mass ratio] in Urine | Normetanephrine/Creatinine |
| 34348-3 | Normetanephrine/Creatinine [Molecular ratio] in Urine | Normetanephrine/Creatinine |
| 44342-4 | Normetanephrine/Creatinine [Mass ratio] in 24 hour Urine | Normetanephrine/Creatinine |
| 44924-9 | Normetanephrine/Creatinine [Molecular ratio] in 24 hour Urine | Normetanephrine/Creatinine |
| 10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma | Normethsuximide |
| 10890-2 | None | Normethsuximide |
| 39483-3 | Normethsuximide [Molecules/volume] in Serum or Plasma | Normethsuximide |
| 34414-3 | Normianserin [Mass/volume] in Serum or Plasma | Normianserin |
| 34415-0 | Normirtazapine [Mass/volume] in Serum or Plasma | Normirtazapine |
| 715-3 | Normoblasts [#/volume] in Blood | Normoblasts |
| 11104-7 | Normoblasts Basophilic/100 cells in Bone marrow by Microscopy | Normoblasts.basophilic/100 cells |
| 11116-1 | Normoblasts Orthochromic/100 cells in Bone marrow by Microscopy | Normoblasts.orthochromic/100 cells |
| 51717-7 | Normoblasts Orthochromic/100 cells in Blood by Microscopy | Normoblasts.orthochromic/100 cells |
| 11119-5 | Normoblasts Polychromatophilic/100 cells in Bone marrow by Microscopy | Normoblasts.polychromatophilic/100 cells |
| 51718-5 | Normoblasts Polychromatophilic/100 cells in Blood by Microscopy | Normoblasts.polychromatophilic/100 cells |
| 33957-2 | Normoblasts/100 blasts in Blood | Normoblasts/100 blasts |
| 51579-1 | Normoblasts/100 cells in Bone marrow by Microscopy | Normoblasts/100 cells |
| 33990-3 | Normoblasts/100 leukocytes [Ratio] in Blood | Normoblasts/100 leukocytes |
| 33364-1 | Normochromic [Presence] in Blood by Light microscopy | Normochromic |
| 33363-3 | Normocytic [Presence] in Blood by Light microscopy | Normocytic |
| 7794-1 | Normocytic/Normochromic polychromasia [Presence] in Blood by Light microscopy | Normocytic/Normochromic polychromasia |
| 49831-1 | Normorphine [Mass/volume] in Urine | Normorphine |
| 33917-6 | Nornicotine [Mass/volume] in Urine | Nornicotine |
| 49117-5 | Norovirus Ag [Presence] in Stool | Norovirus Ag |
| 10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma | Norparamethadione |
| 27402-7 | Norparamethadione [Mass/volume] in Urine | Norparamethadione |
| 10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma | Norpropoxyphene |
| 17376-5 | Norpropoxyphene [Presence] in Urine by Confirm method | Norpropoxyphene |
| 17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirm method | Norpropoxyphene |
| 19632-9 | Norpropoxyphene [Presence] in Urine by Screen method | Norpropoxyphene |
| 19635-2 | Norpropoxyphene [Mass/volume] in Urine | Norpropoxyphene |
| 27029-8 | Norpropoxyphene [Mass/mass] in Meconium | Norpropoxyphene |
| 27041-3 | Norpropoxyphene [Mass/mass] in Stool | Norpropoxyphene |
| 27211-2 | Norpropoxyphene [Mass/mass] in Hair | Norpropoxyphene |
| 29387-8 | Norpropoxyphene [Mass/volume] in Gastric fluid | Norpropoxyphene |
| 35626-1 | Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method | Norpropoxyphene |
| 3870-3 | Norpropoxyphene [Presence] in Serum or Plasma | Norpropoxyphene |
| 3871-1 | Norpropoxyphene [Presence] in Urine | Norpropoxyphene |
| 48960-9 | Norpropoxyphene [Mass/volume] in Unspecified specimen | Norpropoxyphene |
| 19636-0 | Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method | Norpropoxyphene cutoff |
| 19637-8 | Norpropoxyphene cutoff [Mass/volume] in Urine for Confirm method | Norpropoxyphene cutoff |
| 13557-4 | Norsertraline [Presence] in Serum or Plasma | Norsertraline |
| 25724-6 | None | Norsertraline |
| 6897-3 | Norsertraline [Mass/volume] in Serum or Plasma | Norsertraline |
| 43239-3 | Norsildenafil [Mass/volume] in Serum or Plasma | Norsildenafil |
| 49083-9 | None | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) panel |
| 49143-1 | None | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel |
| 12438-8 | Nortramadol [Mass/volume] in Serum or Plasma | Nortramadol |
| 18338-4 | Nortramadol [Mass/volume] in Urine | Nortramadol |
| 18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirm method | Nortramadol |
| 18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirm method | Nortramadol |
| 12444-6 | Nortrimipramine [Mass/volume] in Urine | Nortrimipramine |
| 16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma | Nortrimipramine |
| 25394-8 | Nortrimipramine [Molecules/volume] in Serum or Plasma | Nortrimipramine |
| 49691-9 | Nortrimipramine [Presence] in Serum or Plasma | Nortrimipramine |
| 14856-9 | Nortriptyline [Molecules/volume] in Serum or Plasma | Nortriptyline |
| 29407-4 | Nortriptyline [Mass/volume] in Gastric fluid | Nortriptyline |
| 35627-9 | Nortriptyline [Mass/volume] in Serum or Plasma by Screen method | Nortriptyline |
| 3872-9 | Nortriptyline [Mass/volume] in Serum or Plasma | Nortriptyline |
| 3873-7 | Nortriptyline [Presence] in Serum or Plasma | Nortriptyline |
| 3874-5 | Nortriptyline [Presence] in Urine | Nortriptyline |
| 3875-2 | Nortriptyline [Mass/volume] in Urine | Nortriptyline |
| 40389-9 | Nortriptyline [Presence] in Gastric fluid | Nortriptyline |
| 4361-2 | Nortriptyline [Mass] of Dose | Nortriptyline |
| 45301-9 | Nortriptyline [Molecules/volume] in Urine | Nortriptyline |
| 3876-0 | Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose | Nortriptyline^trough >12h post dose |
| 48362-8 | Norvenlafaxine [Molecules/volume] in Serum or Plasma | Norvenlafaxine |
| 53882-7 | Norvenlafaxine [Mass/volume] in Urine | Norvenlafaxine |
| 9628-9 | Norvenlafaxine [Mass/volume] in Serum or Plasma | Norvenlafaxine |
| 35628-7 | Norverapamil [Presence] in Serum or Plasma by Screen method | Norverapamil |
| 6903-9 | Norverapamil [Mass/volume] in Serum or Plasma | Norverapamil |
| 10696-3 | Norwalk virus [Identifier] in Stool by Electron microscopy | Norwalk virus |
| 7973-1 | Norwalk virus [Presence] in Stool by Electron microscopy | Norwalk virus |
| 40863-3 | Norwalk virus 1 Ag [Identifier] in Stool | Norwalk virus 1 Ag |
| 41035-7 | Norwalk virus RNA [Presence] in Unspecified specimen by DNA probe | Norwalk virus RNA |
| 7974-9 | Norwalk virus RNA [Presence] in Stool by Probe & target amplification method | Norwalk virus RNA |
| 1268-2 | Other Ab [Presence] in Serum or Plasma from Blood product unit | NOS Ab |
| 1269-0 | Other Ab [Presence] in Serum or Plasma from donor | NOS Ab |
| 28163-4 | None | Not enjoying life |
| 34492-9 | NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NOTCH3 gene mutation analysis |
| 41077-9 | NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NOTCH3 gene mutation analysis |
| 34903-5 | None | Note |
| 34906-8 | None | Note |
| 46210-1 | Case manager note | Note |
| 46215-0 | Wound care management note | Note |
| 51855-5 | None | Note |
| 11536-0 | None | Notes |
| 52066-8 | NODMAR (Notice of Discharge Medicare Appeal Rights) Form | Notice of Discharge Medicare Appeal Rights Form attachment |
| 53244-0 | None | Notice of privacy practices receipt attachment |
| 44646-8 | None | Nottingham mitotic count.25x obj |
| 44647-6 | None | Nottingham mitotic count.40x obj |
| 17378-1 | Novobiocin [Mass/volume] in Serum or Plasma | Novobiocin |
| 18957-1 | Novobiocin [Susceptibility] | Novobiocin |
| 370-7 | Novobiocin [Susceptibility] by Minimum lethal concentration (MLC) | Novobiocin |
| 371-5 | Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) | Novobiocin |
| 372-3 | Novobiocin [Susceptibility] by Disk diffusion (KB) | Novobiocin |
| 373-1 | Novobiocin [Susceptibility] by Serum bactericidal titer | Novobiocin |
| 41706-3 | Novobiocin [Susceptibility] by Gradient strip (E-test) | Novobiocin |
| 49864-2 | Novocaine IgE Ab [Units/volume] in Serum | Novocaine Ab.IgE |
| 34505-8 | NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NPDC gene mutation analysis |
| 41076-1 | NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NPDC gene mutation analysis |
| 34512-4 | NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NPHS1 gene mutation analysis |
| 34513-2 | NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Narrative | NPHS1 gene mutation analysis |
| 41074-6 | NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal | NPHS1 gene mutation analysis |
| 41075-3 | NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NPHS1 gene mutation analysis |
| 34739-3 | NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | NR0B1 gene mutation analysis |
| 41073-8 | NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NR0B1 gene mutation analysis |
| 21719-0 | NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | NRAS gene mutation analysis |
| 53621-9 | NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal | NRAS gene mutation analysis |
| 21720-8 | NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | NRAS gene mutations tested for |
| 44621-1 | None | Nregional lymph nodes identified |
| 35645-1 | NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method | NSD1 gene deletion |
| 47967-5 | NSD1 gene mutations found [Presence] in Blood or Tissue by Molecular genetics method | NSD1 gene mutation analysis |
| 13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence | Nuclear Ab |
| 13111-0 | None | Nuclear Ab |
| 13112-8 | None | Nuclear Ab |
| 14607-6 | Nuclear Ab [Presence] in Body fluid | Nuclear Ab |
| 14608-4 | Nuclear Ab [Presence] in Pleural fluid | Nuclear Ab |
| 14609-2 | Nuclear Ab [Presence] in Peritoneal fluid | Nuclear Ab |
| 14610-0 | Nuclear Ab [Presence] in Synovial fluid | Nuclear Ab |
| 14612-6 | Nuclear Ab [Titer] in Pericardial fluid | Nuclear Ab |
| 14613-4 | Nuclear Ab [Titer] in Body fluid | Nuclear Ab |
| 14614-2 | Nuclear Ab [Titer] in Pleural fluid | Nuclear Ab |
| 14615-9 | Nuclear Ab [Titer] in Peritoneal fluid | Nuclear Ab |
| 14616-7 | Nuclear Ab [Titer] in Synovial fluid | Nuclear Ab |
| 16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate | Nuclear Ab |
| 16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate | Nuclear Ab |
| 16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence | Nuclear Ab |
| 21423-9 | Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver | Nuclear Ab |
| 27200-5 | Nuclear Ab [Units/volume] in Serum | Nuclear Ab |
| 29953-7 | Nuclear Ab [Titer] in Serum | Nuclear Ab |
| 31540-8 | Nuclear Ab [Units/volume] in Body fluid | Nuclear Ab |
| 31541-6 | Nuclear Ab [Units/volume] in Pericardial fluid | Nuclear Ab |
| 31542-4 | Nuclear Ab [Units/volume] in Pleural fluid | Nuclear Ab |
| 31543-2 | Nuclear Ab [Units/volume] in Peritoneal fluid | Nuclear Ab |
| 31544-0 | Nuclear Ab [Units/volume] in Synovial fluid | Nuclear Ab |
| 33253-6 | Nuclear Ab [Titer] in Serum by Hep2 substrate | Nuclear Ab |
| 40655-3 | Nuclear Ab [Titer] in Serum by Immunoassay | Nuclear Ab |
| 42254-3 | Nuclear Ab [Presence] in Serum by Immunofluorescence | Nuclear Ab |
| 44751-6 | Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney | Nuclear Ab |
| 44752-4 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence (IF) rat kidney | Nuclear Ab |
| 47383-5 | Nuclear Ab [Presence] in Serum by Immunoassay | Nuclear Ab |
| 5047-6 | Nuclear Ab [Units/volume] in Serum by Immunoassay | Nuclear Ab |
| 5048-4 | Nuclear Ab [Titer] in Serum by Immunofluorescence | Nuclear Ab |
| 6822-1 | Nuclear Ab [Titer] in Synovial fluid by Indirect fluorescence antibody (IFA) | Nuclear Ab |
| 8061-4 | Nuclear Ab [Presence] in Serum | Nuclear Ab |
| 9423-5 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence | Nuclear Ab |
| 13067-4 | Nuclear Ab pattern [interpretation] in Body fluid by Immunofluorescence | Nuclear Ab pattern |
| 13068-2 | Nuclear Ab pattern [interpretation] in Serum by Immunofluorescence | Nuclear Ab pattern |
| 14611-8 | Nuclear Ab pattern [interpretation] in Serum | Nuclear Ab pattern |
| 49309-8 | Nuclear Ab pattern [interpretation] in Body fluid by Immunofluorescence Narrative | Nuclear Ab pattern |
| 49310-6 | Nuclear Ab pattern [interpretation] in Serum Narrative | Nuclear Ab pattern |
| 49311-4 | Nuclear Ab pattern [interpretation] in Serum by Immunofluorescence Narrative | Nuclear Ab pattern |
| 53987-4 | Nuclear Ab pattern.atypic speckled [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.atypic speckled |
| 53988-2 | Nuclear Ab pattern.atypic speckled [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.atypic speckled |
| 53993-2 | Nuclear Ab pattern.centrosomal [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.centrosomal |
| 53994-0 | Nuclear Ab pattern.centrosomal [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.centrosomal |
| 53989-0 | Nuclear Ab pattern.chromosomal [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.chromosomal |
| 53990-8 | Nuclear Ab pattern.chromosomal [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.chromosomal |
| 53985-8 | Nuclear Ab pattern.course speckled [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.course speckled |
| 53986-6 | Nuclear Ab pattern.course speckled [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.course speckled |
| 53002-2 | Nuclear Ab pattern.fine speckled [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.fine speckled |
| 53984-1 | Nuclear Ab pattern.fine speckled [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.fine speckled |
| 20398-4 | Nuclear Ab Pattern Homogenous [Titer] in Serum | Nuclear Ab pattern.homogeneous |
| 53983-3 | Nuclear Ab Pattern Homogenous [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.homogeneous |
| 53999-9 | Nuclear Ab pattern.multiple nuclear dots [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.multiple nuclear dots |
| 54000-5 | Nuclear Ab pattern.multiple nuclear dots [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.multiple nuclear dots |
| 53997-3 | Nuclear Ab pattern.nuclear dots [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear dots |
| 53998-1 | Nuclear Ab pattern.nuclear dots [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear dots |
| 53995-7 | Nuclear Ab pattern.nuclear matrix [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear matrix |
| 53996-5 | Nuclear Ab pattern.nuclear matrix [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear matrix |
| 54005-4 | Nuclear Ab pattern.nuclear membrane pores [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear membrane pores |
| 54006-2 | Nuclear Ab pattern.nuclear membrane pores [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nuclear membrane pores |
| 20399-2 | Nuclear Ab pattern.nucleolar [Titer] in Serum | Nuclear Ab pattern.nucleolar |
| 42212-1 | Nuclear Ab pattern.nucleolar [Titer] in Body fluid | Nuclear Ab pattern.nucleolar |
| 53991-6 | Nuclear Ab pattern.nucleolar [Titer] in Serum by Immunofluorescence | Nuclear Ab pattern.nucleolar |
| 53992-4 | Nuclear Ab pattern.nucleolar [Presence] in Serum by Immunofluorescence | Nuclear Ab pattern.nucleolar |
| 20400-8 | Nuclear Ab pattern.rim [Titer] in Serum | Nuclear Ab pattern.rim |
| 42213-9 | Nuclear Ab pattern.rim [Titer] in Body fluid | Nuclear Ab pattern.rim |
| 20401-6 | Nuclear Ab pattern.speckled [Titer] in Serum | Nuclear Ab pattern.speckled |
| 42214-7 | Nuclear Ab pattern.speckled [Titer] in Body fluid | Nuclear Ab pattern.speckled |
| 17380-7 | Nuclear Ab.histone reactive [Presence] in Serum | Nuclear Ab.histone reactive |
| 21424-7 | Nuclear IgG Ab [Presence] in Serum by Immunofluorescence | Nuclear Ab.IgG |
| 29950-3 | Nuclear IgG Ab [Presence] in Serum by Immunoassay | Nuclear Ab.IgG |
| 31545-7 | Nuclear IgG Ab [Presence] in Serum | Nuclear Ab.IgG |
| 42331-9 | Nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) | Nuclear Ab.IgG |
| 31134-0 | Nuclear matrix protein 22 [Units/volume] in Urine | Nuclear matrix protein 22 |
| 50666-7 | Nuclear matrix protein 22 [Presence] in Urine | Nuclear matrix protein 22 |
| 34737-7 | Nuclear mitotic apparatus Ab [interpretation] in Serum or Plasma | Nuclear mitotic apparatus Ab |
| 44645-0 | None | Nuclear pleomorphism |
| 54025-2 | Nuclear pore protein gp210 Ab [Presence] in Serum | Nuclear pore protein gp210 Ab |
| 50375-5 | Nucleated cells [#/volume] in Bronchial specimen by Manual count | Nucleated cells |
| 50774-9 | Nucleated cells [#/volume] in Blood | Nucleated cells |
| 51926-4 | Nucleated cells [#/volume] in Peritoneal fluid by Manual count | Nucleated cells |
| 52815-8 | Nucleated cells [#/volume] in Pericardial fluid by Automated count | Nucleated cells |
| 52816-6 | Nucleated cells [#/volume] in Cerebral spinal fluid by Automated count | Nucleated cells |
| 52817-4 | Nucleated cells [#/volume] in Dialysis fluid by Automated count | Nucleated cells |
| 52818-2 | Nucleated cells [#/volume] in Peritoneal fluid by Automated count | Nucleated cells |
| 52819-0 | Nucleated cells [#/volume] in Pleural fluid by Automated count | Nucleated cells |
| 53557-5 | Nucleated cells [#/volume] in Synovial fluid by Manual count | Nucleated cells |
| 34416-8 | Nucleosome Ab [Units/volume] in Serum by Immunoassay | Nucleosome Ab |
| 53014-7 | Nucleosome Ab [Units/volume] in Serum | Nucleosome Ab |
| 53015-4 | Nucleosome Ab [Presence] in Serum | Nucleosome Ab |
| 9800-4 | Number of Stones | Number |
| 45835-6 | None | Number days injections received |
| 45886-9 | None | Number days recreation therapy administered for greater than 15 min |
| 45875-2 | None | Number hospital admissions in last 90 days |
| 30974-0 | None | Number of brothers and sisters |
| 45837-2 | None | Number of days antianxiety medication received |
| 45838-0 | None | Number of days antidepressant medication received |
| 45836-4 | None | Number of days antipsychotic medication received |
| 45840-6 | None | Number of days diuretic medication received |
| 30950-0 | None | Number of days hospitalized due to vaccination adverse event |
| 45839-8 | None | Number of days hypnotic medication received |
| 45860-4 | None | Number of days of active range of motion |
| 45869-5 | None | Number of days of other rehabilitation or restorative techniques or procedures |
| 45859-6 | None | Number of days of passive range of motion |
| 45861-2 | None | Number of days of splint or brace assistance |
| 45867-9 | None | Number of days of training & skill practice in amputation or prosthesis care |
| 45862-0 | None | Number of days of training & skill practice in bed mobility |
| 45868-7 | None | Number of days of training & skill practice in communication |
| 45865-3 | None | Number of days of training & skill practice in dressing or grooming |
| 45866-1 | None | Number of days of training & skill practice in eating or swallowing |
| 45863-8 | None | Number of days of training & skill practice in transfer |
| 45864-6 | None | Number of days of training & skill practice in walking |
| 45878-6 | None | Number of days physician orders changed in last 14 days |
| 45762-2 | None | Number of days with at least 15 minutes of occupational therapy in the last 7 days |
| 45764-8 | None | Number of days with at least 15 minutes of physical therapy in the last 7 days |
| 45768-9 | None | Number of days with at least 15 minutes of psychological therapy in the last 7 days |
| 45766-3 | None | Number of days with at least 15 minutes of respiratory therapy in the last 7 days |
| 45760-6 | None | Number of days with at least 15 minutes of speech language pathology and audiology services in the last 7 days |
| 45876-0 | None | Number of emergency room visits in last 90 days |
| 10581-7 | Number of entities [#] in Spermatazoa | Number of entities |
| 33747-7 | None | Number of fragmented pieces |
| 45248-2 | None | Number of hospital days since last outpatient visit |
| 34049-7 | None | Number of impressions |
| 52478-5 | None | Number of Major Wounds |
| 45833-1 | None | Number of medications |
| 52007-2 | Ambulance transport, number of patients | Number of patients |
| 45877-8 | None | Number of physician visits in last 14 days |
| 46536-9 | None | Number of pressure ulcers - stage 1 |
| 46537-7 | None | Number of pressure ulcers - stage 2 |
| 46538-5 | None | Number of pressure ulcers - stage 3 |
| 46539-3 | None | Number of pressure ulcers - stage 4 |
| 52575-8 | None | Number of pressure ulcers at assessment - stage 2 |
| 52576-6 | None | Number of pressure ulcers at assessment - stage 3 |
| 52577-4 | None | Number of pressure ulcers at assessment - stage 4 |
| 52578-2 | None | Number of pressure ulcers at assessment - unstageable |
| 46460-2 | None | Number of pressure ulcers at each stage |
| 52579-0 | None | Number of pressure ulcers onset during this service - stage 2 |
| 52580-8 | None | Number of pressure ulcers onset during this service - stage 3 |
| 52581-6 | None | Number of pressure ulcers onset during this service - stage 4 |
| 52582-4 | None | Number of pressure ulcers onset during this service - unstageable |
| 30960-9 | None | Number of previous doses |
| 21959-2 | None | Number of radiation Rx |
| 19800-2 | None | Number of specimens obtained |
| 42185-9 | Number of specimens obtained of Unspecified specimen | Number of specimens obtained |
| 38527-8 | Number of specimens received of Study Stool | Number of specimens received |
| 42186-7 | Number of specimens received of Unspecified specimen | Number of specimens received |
| 38526-0 | Number of specimens tested of Study Stool | Number of specimens tested |
| 42187-5 | Number of specimens tested of Unspecified specimen | Number of specimens tested |
| 46544-3 | None | Number of stasis ulcers |
| 41950-7 | None | Number of steps |
| 41951-5 | None | Number of steps |
| 41952-3 | None | Number of steps |
| 46548-4 | None | Number of surgical wounds |
| 44656-7 | None | Number of tissue chips |
| 42033-1 | None | Number of tumors & histologies |
| 42032-3 | None | Number of tumors at diagnosis |
| 52476-9 | None | Number of unhealed pressure ulcers at each stage |
| 52583-2 | None | Number of unhealed stage 2 ulcers known to be present for more than 1 month |
| 11543-6 | Nursery records | Nursery records |
| 34080-2 | None | Nursing mothers section |
| 46208-5 | Nursing notes | Nursing notes |
| 46066-7 | None | Nursing rehabilitation and restorative care |
| 52836-4 | None | Nursing unit cost center |
| 52835-6 | None | Nursing unit name |
| 6188-7 | Nutmeg IgE Ab [Units/volume] in Serum | Nutmeg Ab.IgE |
| 15874-1 | Nutmeg IgE Ab RAST class in Serum | Nutmeg Ab.IgE.RAST class |
| 7527-5 | Nutmeg IgG Ab [Units/volume] in Serum | Nutmeg Ab.IgG |
| 21425-4 | Nutmeg IgG Ab RAST class in Serum | Nutmeg Ab.IgG.RAST class |
| 28181-6 | None | Nutrition alteration |
| 38225-9 | None | Nutrition intake pattern |
| 45794-5 | None | Nutrition or hydration intervention to manage skin problems |
| 39200-1 | None | Nutrition screen assessment |
| 39203-5 | None | Nutrition screen finding recency |
| 39202-7 | None | Nutrition screen follow-up status |
| 39201-9 | None | Nutrition screen results indicator |
| 28314-3 | None | Nutrition.behavior |
| 28495-0 | None | Nutrition.behavior |
| 46846-2 | None | Nutrition.behavior |
| 28315-0 | None | Nutrition.knowledge |
| 28496-8 | None | Nutrition.knowledge |
| 46847-0 | None | Nutrition.knowledge |
| 28316-8 | None | Nutrition.status |
| 28497-6 | None | Nutrition.status |
| 46848-8 | None | Nutrition.status |
| 46042-8 | None | Nutritional approaches |
| 46148-3 | None | Nutritional approaches (quarterly RUG-III) |
| 46139-2 | None | Nutritional approaches (quarterly) |
| 45749-9 | None | Nutritional approaches - none of above |
| 46041-0 | None | Nutritional problems |
| 45740-8 | None | Nutritional problems - none of above |
| 50056-1 | Nutritional risk index | Nutritional risk index |
| 45909-9 | None | Nutritional status trigger |
| 29085-8 | None | Nystagmus examination |
| 29086-6 | None | Nystagmus examination |
| 29758-0 | None | Nystagmus examination |
| 29759-8 | None | Nystagmus examination |
| 10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nystatin |
| 10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | Nystatin |
| 18958-9 | Nystatin [Susceptibility] | Nystatin |
| 35824-2 | Nystatin [Susceptibility] by Disk diffusion (KB) | Nystatin |